WO2018107486A1 - Method of drying decellularized cornea and dried decellularized pig lamellar cornea - Google Patents

Method of drying decellularized cornea and dried decellularized pig lamellar cornea Download PDF

Info

Publication number
WO2018107486A1
WO2018107486A1 PCT/CN2016/110464 CN2016110464W WO2018107486A1 WO 2018107486 A1 WO2018107486 A1 WO 2018107486A1 CN 2016110464 W CN2016110464 W CN 2016110464W WO 2018107486 A1 WO2018107486 A1 WO 2018107486A1
Authority
WO
WIPO (PCT)
Prior art keywords
drying
cornea
pressure
decellularized
dried
Prior art date
Application number
PCT/CN2016/110464
Other languages
French (fr)
Chinese (zh)
Inventor
詹晓亮
李洁
李志寒
董晓鸥
刘靖
Original Assignee
厦门大开生物科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 厦门大开生物科技有限公司 filed Critical 厦门大开生物科技有限公司
Priority to PCT/CN2016/110464 priority Critical patent/WO2018107486A1/en
Priority to CN201680077793.4A priority patent/CN109069264B/en
Publication of WO2018107486A1 publication Critical patent/WO2018107486A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells

Definitions

  • the present invention relates to a method for preparing an artificial cornea for treating corneal blinding eye diseases, in particular to a method for drying a decellularized cornea and a decellularized lamellar dried cornea using a porcine cornea as a donor source.
  • Corneal transplantation is currently the only effective method for treating corneal blindness. Due to the serious lack of status of corneal donors in China, it has greatly affected the wide-scale promotion of this operation, but it has also made China's research in the field of heterogeneous corneal replacement a world-famous The achievements, especially the application of acellular porcine lamellar cornea with porcine cornea as donor source, have been praised by foreign scientific circles as one of the five major innovations in contemporary China.
  • the porcine cornea has a tissue structure, biophysical properties and optical properties similar to human cornea height, which is the accepted conclusion of the best choice for corneal substitutes.
  • the domestic ophthalmologists have successfully realized the transplantation of the porcine lamellar cornea directly into the human body, and achieved certain clinical effects.
  • the artificial cornea with porcine cornea as the material has many advantages such as wide material source, low cost, simple treatment method and good clinical effect compared with other artificial cornea techniques.
  • Two domestic companies have developed artificial corneal products with porcine cornea as donor source, which has been applied to the clinic through market access approval of relevant Chinese regulatory authorities, bringing good news to patients with corneal diseases and bringing a huge market demand. .
  • the lamellar cornea is a cornea (scaffold) comprising only the lamella structure of the front elastic layer and the matrix layer with respect to the cornea of the full-layer structure. It is available in three forms: unseasoned lamellar scaffold (referred to as water content dehydrated to the original cornea), dry lamellar scaffold and rehydred lamellar scaffold. (See the applicant's prior application No. CN10197144).
  • unseasoned lamellar scaffold referred to as water content dehydrated to the original cornea
  • dry lamellar scaffold referred to as dry lamellar scaffold and rehydred lamellar scaffold.
  • the test data or clinical effects are not exactly the same.
  • the so-called corneal products and their application effects are only based on the test data state of the non-dried cornea, and there is no condition that can be promoted and used in the market, that is, in production and preservation. , product quality and performance stability at every stage of market operations such as transportation and use.
  • the biggest drawback of non-dried corneas is that they are extremely difficult to store and transport.
  • the quality and biophysical properties of the non-drying lamellar cornea will be preserved and transported.
  • the change in the conditions of the change changes with it, and this change is unpredictable. Therefore, the doctor cannot judge the postoperative effect that the artificial cornea used can be achieved in the clinic.
  • the clinical effect of using such artificial corneal transplantation on the market is that, even if the operation is successful, the time for postoperative recovery needs to be as long as 3 months to 6 months.
  • the current researchers have proposed a method of drying the cornea after decellularization to obtain a dry cornea which is easy to store and transport.
  • many of the alternative drying methods currently proposed are conventional drying methods.
  • the currently disclosed methods of drying the cornea mainly include freeze-drying, dehydration of glycerin, dehydration of denaturing silica, dehydration of phosphorus pentoxide and dehydration of anhydrous calcium chloride, and are widely used in conventional drying techniques in the field of medical devices.
  • the Applicant has exhausted all of the conventional drying methods to perform extensive drying treatment tests on artificial corneas.
  • any conventional drying process would have a certain degree of adverse effect on the biophysical properties of the artificial cornea.
  • the present inventors have conducted research and statistical analysis on a large amount of test data obtained by each drying method in the drying process, and found that the above-mentioned conventional drying method has an adverse effect on the artificial cornea because the drying process is too severe.
  • the collagen scaffold becomes very loose due to the large amount of water contained in the cornea and the gap existing after the removal of the cells, and at the same time, the supporting force of the collagen arrangement in the original matrix layer is lost. In this state, the violent drying process inevitably causes an irregular change in the arrangement of the collagen tissue, thereby destroying the highly regular arrangement of the collagen fibers in the original corneal stroma.
  • the cornea has distinct characteristics that are different from all other tissues: transparent. This is also the most important basis for the cornea to perform its physiological functions.
  • the transparency of the cornea is derived from the highly regular arrangement of collagen fibers in the matrix layer.
  • the highly regular arrangement of collagen fibers in the corneal stroma is also the structural basis of the mechanical elasticity of the cornea.
  • vacuum drying is achieved by lowering the pressure by lowering the pressure (dry boiling point) or melting point (freeze drying) in a closed environment, the vaporization or sublimation of moisture in the object is accelerated, thereby achieving rapid drying.
  • boiling point drying is a process of high temperature drying. During the drying process, the moisture in the material is simultaneously evaporated and boiled under sufficient heat. Although the boiling point of the water is lowered in the low pressure state, a certain amount of heat is required to ensure that the water in the dried object reaches the evaporation and boiling state. It is violent.
  • the boiling point drying method is rarely used to dry the cornea.
  • the moisture of the material is first frozen to a solid state, and then the solid water is directly sublimated into a gaseous state under a high vacuum to be removed.
  • This method does not have a high temperature and violent reaction such as evaporation and boiling in boiling point drying, and is a drying method which is widely used in biological materials.
  • the drying method is based on lowering the boiling point of water under low pressure conditions, the ice crystals in the tissue are sublimated into a vapor state and removed, and the volume occupied by the ice crystals forms a pore-like structure.
  • Patent No. CN 104188957 proposes a natural drying method which is basically the same as that of a non-natural factor that is sterile and air-dried, that is, the acellular corneal stroma is placed in a 24-well plate culture plate and placed in a clean bench for 48°. 72 hours.
  • the drawback of this natural drying method is that the drying time is too long, which tends to cause collagen denaturation of the cornea, thereby affecting the transparency of the cornea. And throughout all drying time, The maintenance of the sterility of the environment is quite difficult.
  • other conditions such as temperature control, wind adjustment, etc., which are naturally dried, are difficult to control, and the degree of drying and drying time are difficult to control.
  • the influence of other uncontrollable factors in the natural environment will result in different drying effects. Even the corneal drying in the same batch will be uneven and the drying effect will be different, and the drying effect of all batches cannot be guaranteed to be the same. Therefore, the current natural drying method is only applicable to the laboratory or small batch production conditions, and basically cannot be applied to large-scale industrial scale production. This is also the reason why there is basically no adoption in the field of medical device industrialization.
  • the method is to seal the non-dried cornea in glycerin.
  • This method is mainly a process in which the cornea is stored in a glycerin liquid and is gradually dehydrated during storage.
  • the defects are also obvious.
  • the liquid preservation state is not conducive to transportation, and glycerin is prone to explosion and other safety hazards during transportation.
  • the gradual dehydration process is difficult to ensure the quality of the cornea in clinical use. It is also impossible to regulate the corneal transplantation. It is necessary for the doctor to make adaptive changes according to the preservation state of the cornea at the time of clinical use.
  • the non-dried cornea cannot modify its shape. For example, the shape of the cornea is corrected based on the diopter requirements of the transplanted cornea.
  • the higher the transparency the higher the transparency of the recovery after transplantation.
  • the water content is basically the same.
  • the dry cornea can regulate the rehydration operation of the transplant, which can effectively control the rehydration of the cornea after rehydration. It is beneficial to shorten the time of transparency after corneal surgery.
  • the flatness of the cornea, especially the higher the level of the pre-corneal elastic layer, is more conducive to the attachment and proliferation of epithelial cells. Uneven or dry corneas with visually visible verrucous protrusions or fine folds can affect the healing effect after transplantation to varying degrees.
  • the object of the present invention is to provide a method for drying acellular cornea, which makes the cornea drying process more The mildening minimizes the destruction of the corneal collagen fiber alignment structure during the drying process, so that the cornea after drying has the same physical properties as the cornea before drying.
  • Another object of the present invention is to provide a method for drying a decellularized cornea and a dry cornea thereof, which improves the transparency of the cornea after drying to facilitate shortening the time for recovery of transparency after corneal implantation.
  • a further object of the present invention is to provide a method for drying acellular cornea and a dry cornea thereof, which improves the flatness of the appearance of the dried cornea, in particular, the flatness of the pre-corneal elastic layer to facilitate the growth of epithelial cells after corneal implantation. Speed and growth quality.
  • a fourth object of the present invention is to provide a method for drying a decellularized cornea and a dried cornea, which are convenient for storage and transportation, and which provide artificial corneal with product properties of market circulation. Promote the standardization, industrialization and market development of artificial corneal products to meet the huge market demand for artificial corneas.
  • the fifth object of the present invention is to provide a method for drying acellular cornea and a dry cornea, which can conveniently perform precise correction processing on the cornea according to requirements, in particular, processing corneal diopter, and expanding artificial cornea in refractive correction.
  • the object of the present invention is achieved by a method for drying a decellularized cornea, which is first placed on a support device and placed in a closed drying chamber with adjustable vacuum; and the vacuum drying system is used to reduce the closed drying chamber.
  • the pressure is lower than the atmospheric pressure; and the pressure in the closed drying chamber is gradually reduced to a set maximum pressure during a period of time, and continues to reach the corneal drying under the set maximum vacuum state. Degree requirements.
  • the working principle of the invention is that after the cornea to be dried is placed in a closed drying chamber with adjustable vacuum degree, the pressure in the vacuum drying chamber is set at a pressure lower than atmospheric pressure but higher than the maximum vacuum of the drying chamber. And through the adjustment system, the pressure of the closed drying chamber is gradually adjusted to the set maximum vacuum until the cornea reaches its set dryness requirement.
  • the vacuum drying process of the present invention becomes gentler, thereby overcoming the drawback that the drying process of the prior drying method is too severe. Therefore, the present invention minimizes the degree of destruction of collagen regular alignment of the matrix layer during corneal drying.
  • the dried cornea obtained by the drying method of the present invention has substantially no further destructive collagen arrangement of the matrix layer before drying. change.
  • the drying method of the present invention is suitable for the drying treatment of the full-thickness cornea and lamellar cornea.
  • the pressure reduction mode in the closed drying chamber is at least two stages from high to low gradient pressure reduction, and the pressure gradient of each stage lasts for a period of time; stress reliever To the set maximum vacuum state.
  • the preferred embodiment is more convenient to operate and easier to control.
  • the decompression range of each gradient is 10 100 kpa; wherein the preferential decompression range is 10 ⁇ 30 kPa.
  • the duration of the pressure gradient for each stage is set to decrease as the pressure decreases.
  • the vacuum adjustment system adjusts the previous stage pressure block to adjust directly to the subsequent stage pressure block as the pressure gradient changes.
  • the vacuum adjustment system adjusts the previous stage pressure differential to gradually decrease to the next stage pressure differential as the pressure gradient changes.
  • the duration of each stage of the reduced pressure gradient is 0.5 12 hours; wherein the priority duration is 0.54 hours.
  • the method of controlling the pressure reduction in the sealed drying chamber is to continuously reduce the pressure to a set maximum vacuum state for a period of time.
  • the operation of the reduced pressure can be achieved by means of automatic control.
  • the temperature in the enclosed drying chamber is controlled between 0 ° C and 30 ° C.
  • the vacuum adjustment system adjusts the pressure at which the pressure of the closed drying chamber is reduced to a set maximum vacuum within no more than 24 hours; wherein the pressure is preferentially set to 6 to 11 hours. The maximum vacuum when the pressure.
  • the pressure regulating range of the closed drying chamber is from atmospheric pressure to a set maximum vacuum.
  • the set maximum vacuum is at a pressure close to the ultimate vacuum.
  • the corneal dryness is set according to the corneal moisture content.
  • the corneal dryness is optimally set to a moisture content of no greater than 20%.
  • the invention provides a decellularized porcine dry cornea, which comprises a decellularized porcine corneal anterior elastic layer and a matrix layer, and is obtained by any of the above drying methods.
  • the moisture content of the dried cornea is greater than 0% and not greater than 20%.
  • the light transmittance of the dried cornea is not less than 70%.
  • the surface of the dried cornea is flat, with no visible ridges or fine folds visible to the naked eye.
  • the present invention is based on the principle of vacuum drying, so that the vacuum drying temperature is low, there is no overheating, the water is easy to evaporate, and when dry Short advantage.
  • the excessively severe drying defects in the conventional vacuum drying method are effectively overcome by the gradual decompression method, so that the vacuum drying process becomes gentler. Therefore, the degree of regular destruction of collagen fibers in the matrix layer during corneal drying is minimized.
  • the dried cornea obtained by the drying method of the present invention has substantially no further damage of the collagen fibers of the matrix layer before drying. Sexual change.
  • the cornea After drying, the cornea is kept to the maximum of the same biophysical properties as the cornea before drying.
  • the test results show that the dried cornea obtained by the drying method of the method has higher transparency and smooth surface than the dried cornea obtained by the conventional drying method, and has excellent flatness visible to the naked eye.
  • the clinical effect of the dried cornea of the present invention is more remarkable: First, the dried cornea of the present invention begins to gradually become transparent during the corneal transplantation.
  • the dry cornea obtained by the drying method of the present invention greatly reduces the time for recovery of the cornea after implantation due to the curing period of at least 3 months compared to the existing dry cornea.
  • the flatness of the dried cornea based on the present invention is extremely high, and another significant clinical effect is that the postoperative epithelial cells adhere and proliferate quickly and have a good effect.
  • Another important technical effect of the present invention is that the entire drying process of the present invention is carried out in a vacuum-tight environment, greatly reducing the chance of contact between the cornea and the air, and effectively avoiding contamination as compared with natural drying. Therefore, the present invention can satisfy corneal conditions in large quantities.
  • all influencing factors such as temperature, decompression curve, and drying time are controllable, and the pre-dry state of the cornea obtained by different decellularization methods can be used, and various decompression methods most suitable for the cornea are used.
  • the dried cornea obtained by the drying method of the present invention has characteristics of stable performance with respect to the non-dried cornea. It can be cleaned by the simplest method of cryopreservation (such as 0 ⁇ 8 degree cryopreservation in the refrigerator). Its quality and characteristics will not change its performance due to the length of storage or other factors, ensuring that the dried cornea is preserved and transported. After entering the clinical use state, the quality identity can still be guaranteed, and the purpose of preservation and transportation can be achieved.
  • the dry cornea has the necessary conditions for industrialization and marketization as a product, which is beneficial to the market of artificial cornea.
  • the dried cornea obtained by the drying method of the present invention has a mechanical processing property similar to that of a chemical contact lens when the water content is less than 10 to 15%. It is convenient to accurately process the shape of the cornea according to the requirements to achieve the special needs of corneal grafting. In particular, the processing of dry corneal diopter, the application of artificial cornea in refractive correction.
  • the biomatrix cornea of the present invention has incomparable biocompatibility with respect to chemical contact lenses.
  • Figure 1 shows a first embodiment of the gradient decompression of the present invention
  • Figure 2 is a second embodiment of the gradient decompression of the present invention.
  • Figure 3 is a third embodiment of the gradient decompression of the present invention.
  • Figure 4 is a fourth embodiment of the gradient decompression of the present invention.
  • Figure 5 is a fifth embodiment of the gradient decompression of the present invention.
  • Figure 6 is a first embodiment of continuous decompression of the present invention.
  • Figure 7 is a second embodiment of the continuous decompression of the present invention.
  • Figure 8 is a third embodiment of the continuous decompression of the present invention.
  • Figure 10 is an ultrastructure of the lamellar dry corneal electron microscope of the present invention.
  • Figure 11 is a photograph of the dried corneal transparency of the ply of the present invention.
  • Figure 12 is a photograph of a 3-day postoperative lamellar keratoplasty of the present invention.
  • the invention provides a method for drying a decellularized cornea, which is first placed on a supporting device and placed in a closed drying chamber with adjustable vacuum; as shown in FIG. 1 to FIG. 7, the vacuum regulating system is adopted.
  • the pressure in the closed drying chamber is depressurized to a set maximum vacuum degree for a period of time, and continues to reach the requirement of corneal dryness under the set maximum vacuum state, thereby obtaining a dried cornea.
  • the drying method of the present invention is based on the principle of vacuum drying, and therefore has the advantages of low vacuum drying temperature, no overheating, easy evaporation of water, and short drying time.
  • the present invention adopts a method of gradually depressurizing by a period of time, the existing vacuum drying is effectively overcome to directly adjust the pressure to the maximum degree of vacuum, thereby causing the drying process to be too severe.
  • the present invention makes the process of vacuum drying more gentle, and thus minimizes the degree of regular destruction of collagen fibers in the matrix layer during corneal drying.
  • the dried cornea obtained by the drying method of the present invention the collagen fibers of the matrix layer are arranged and dried substantially before drying. There is no destructive change, and the cornea is kept to a maximum of biophysical properties that are substantially similar to the fresh cornea before drying.
  • the dried cornea obtained by the drying method of the present invention has a moisture content of the dried cornea of not more than 20%.
  • the light transmittance is not less than 70%.
  • the surface of the dried cornea is flat, with no visible protrusions or fine folds visible to the naked eye.
  • the clinical effect of the dried cornea obtained by the drying method of the present invention is remarkable: First, the dried cornea begins to gradually become transparent during the corneal transplantation.
  • the dry cornea obtained by the drying method of the present invention greatly shortens the time for achieving transparency after corneal implantation, compared to the existing artificial cornea requiring a clear period of at least 3 months.
  • another significant clinical effect is that the postoperative epithelial cell attachment and proliferation rate is fast.
  • Figs. 9 to 10 the ultrastructure and appearance of the dried artificial cornea obtained by the drying method of the present invention are shown. It can be seen from the dry corneal structure under the electron microscope shown in FIG. 9 to FIG. 10 that the cornea of the present invention retains the fine structure of the collagen tissue at a maximum, and the structural damage is small, and the average gap between the collagen fibers is uniform (25). ⁇ 10nm).
  • the dried cornea of the present invention has an extremely high transparency and a smooth surface, and has excellent flatness which is visually visible to the naked eye. Through animal experiments, its performance is closest to that of human cornea.
  • Fig. 12 and Fig. 13 are photographs showing the dry cornea shown in Example 1 at 3 and 2 months after human corneal transplantation. It can be seen from the postoperative effect photographs of Fig. 11 and Fig. 12 that the dried cornea of the present invention has been in a transparent state 3 days after the operation, the corneal epithelium is basically repaired, no obvious rejection reaction is observed, and the cornea is completely recovered 2 months after the operation. Transparent, no neovascularization, no rejection.
  • the temperature in the closed drying chamber is controlled within a range of 0 ° C to 30 ° C.
  • the pressure in the closed drying chamber ranges from atmospheric pressure to the set maximum vacuum.
  • the set maximum vacuum may be the set maximum vacuum.
  • the maximum vacuum that can be achieved by the equipment varies depending on the equipment of each closed drying chamber. In the present invention, the pressure at the set maximum vacuum is close to the ultimate vacuum.
  • the pressure refers to a pressure value that the vacuum regulating system needs to adjust to adjust the closed drying chamber, and is not the measured pressure value in the closed drying chamber.
  • the decompression mode in the closed drying chamber is decompressed from a high to low gradient in at least two stages, and continues for a period of time on the pressure gradient of each stage; Then depressurize to the maximum vacuum state.
  • the decompression value of each gradient is 10 ⁇ 50kpa.
  • the duration of each stage of the decompression gradient is 30 minutes to 4 hours.
  • the vacuum regulating system adjusts the first stage pressure stop to instantaneously decrease to the next stage pressure block.
  • the artificial cornea that needs to be dried is placed on the support device and placed in a vacuum drying oven at 0 ° C to 30 ° C;
  • the second step is to control the vacuum regulation system and start the gradient decompression operation.
  • the pressure control curve is shown in Figure 1.
  • the decompression gradient is 80kpa, 60kpa, 40kpa, 20kpa, and the duration is 2h, 2h, 2h, lh respectively. ;
  • the pressure is reduced to the maximum vacuum of the device.
  • the maximum vacuum of the device is 0.5 kPa, and then the artificial cornea is completely dried.
  • the duration is about 1 hour in the maximum vacuum state of the device.
  • the pressure is gradually reduced to a maximum vacuum of the apparatus over a period of about 7 hours through a plurality of gradient levels, and then the corneal drying requirement is reached after a maximum vacuum of about 1 hour.
  • the multi-gradient decompression method of the present embodiment has a milder drying process, thereby minimizing the regular arrangement of the collagen fibers in the matrix layer during the corneal drying process. The damage, so that the dried corneal product after drying can maintain good transparency and appearance flatness.
  • the method of the low-temperature gradient vacuum drying method of the present embodiment greatly shortens the time compared with the natural drying, effectively reduces the denaturation of the corneal protein, and maintains the transparency of the cornea while ensuring the consistency of the corneal product.
  • the dried cornea obtained by the gradient decompression method of the present embodiment has a moisture content of 10 ⁇ 2% and a light transmittance of 90 ⁇ 2%.
  • the surface of the dried cornea is flat, with no visible protrusions or fine folds as shown in Figure 11.
  • Example 2
  • the gradient is used to reduce the pressure from 60 kPa to the maximum vacuum of 0.3 kpa through two steps.
  • the vacuum adjustment system adjusts the previous stage pressure block to instantaneously adjust to the next stage pressure block.
  • the duration of the pressure gradient for each stage is set to decrease as the pressure decreases.
  • the drying steps of this embodiment are as follows:
  • the artificial cornea that needs to be dried is placed on the support device and placed in a vacuum drying oven at 0 ° C to 30 ° C;
  • the second step is to control the vacuum regulation system and start the gradient decompression operation.
  • the decompression curve is shown in Figure 2.
  • the decompression gradient is 60kpa and 30kpa, and the duration is 4h and 4h respectively .
  • the third step continue to decompress until the maximum vacuum of the device is 0.3kpa, and then keep until the artificial cornea is completely dry.
  • the duration is approximately 1 hour.
  • the pressure is gradually reduced to about the maximum vacuum of the apparatus for about 8 hours, and then the corneal drying requirement is reached after the maximum vacuum for about one hour.
  • the dried cornea With the dried cornea obtained by the gradient decompression method of this example, the dried cornea has a water content of 18 ⁇ 2% and a light transmittance of 82 ⁇ 2%. The surface of the dried cornea is flat and has no visible protrusions or fine folds.
  • Example 3
  • the pressure is reduced from lOlkpa to a maximum vacuum of 0.3 kpa through nine steps using a gradient decompression method.
  • the vacuum adjustment system adjusts the first stage pressure block to instantaneously lower to the next stage pressure block.
  • the pressure gradient of each stage of decompression is not evenly distributed.
  • the artificial cornea that needs to be dried is placed on the support device and placed in a drying oven at 0 ° C ⁇ 30 ° C;
  • the second step is to control the vacuum regulation system and start the gradient decompression operation.
  • the decompression curve is shown in Figure 3.
  • the decompression gradients are 85kpa, 70kpa, 60kpa, 45kpa, 35kpa, 25kpa, 15kpa, respectively. 2h, 2h, 2h, 1.5h, 1.5h, lh, lh;
  • the third step continue to decompress until the maximum vacuum of the device is 0.3kpa, and then keep until the artificial cornea is completely dry.
  • the duration is approximately 1 hour.
  • the pressure is gradually reduced to about the maximum vacuum of the apparatus for about 11 hours, and then the corneal drying requirement is reached after about 1 hour at the maximum vacuum.
  • the dried cornea obtained by the gradient decompression method of the present embodiment has a moisture content of 5 ⁇ 0.5% and a light transmittance of 85 ⁇ 2%. Dry corneal surface is flat, no macroscopically visible ridges or small Wrinkles.
  • the pressure is reduced from 50 kPa to the maximum vacuum of the device by 0.2 kPa by means of gradient decompression.
  • the vacuum adjustment system adjusts the first stage pressure block to instantaneously lower to the next stage pressure block.
  • the pressure gradient of each stage of decompression is not evenly distributed.
  • the artificial cornea that needs to be dried is placed on the support device and placed in a drying oven at 0 ° C ⁇ 30 ° C;
  • the second step is to control the vacuum regulation system and start the gradient decompression operation.
  • the decompression curve is shown in Figure 4.
  • the decompression gradient is 50kpa, 30kpa, 15kpa, and the duration is 3h, 2h, lh, respectively.
  • the third step continue to decompress to a maximum vacuum of 0.2kpa, and then keep the artificial cornea completely dry.
  • the duration is approximately 1 hour.
  • the pressure is gradually lowered to about the maximum vacuum of the apparatus for about 6 hours, and then the corneal drying requirement is reached after the maximum vacuum for about one hour.
  • the dried cornea obtained by the gradient decompression method of the present embodiment has a moisture content of 18 ⁇ 2% and a light transmittance of 84 ⁇ 2%.
  • the surface of the dried cornea is flat and has no visible protrusions or fine folds.
  • the gradient pressure is reduced by 5 steps to reduce the pressure from 80 kPa to the maximum vacuum of the device of 0.5 kPa.
  • the vacuum regulating system adjusts the pressure of the previous stage to gradually decrease to the pressure of the latter stage.
  • the artificial cornea that needs to be dried is placed on the support device and placed in a drying oven at 0 ° C ⁇ 30 ° C;
  • the second step is to control the vacuum regulation system and start the gradient decompression operation.
  • the decompression curve is shown in Figure 5.
  • the decompression gradient is: Maintain 2h at 80kpa;
  • 80kpa gradually reduced pressure to 60kpa after lh, and maintained lh at 60kpa;
  • 60kpa gradually reduced pressure to 40kpa after lh, and maintained lh at 40kpa;
  • 40kpa gradually depressurizes to 20kpa after lh, and maintains lh at 20kpa;
  • 20kpa is gradually decompressed to a maximum vacuum of 0.5kpa after lh ; then it is kept at 0.5kpa until the artificial cornea is completely dry.
  • the duration is approximately 1 hour.
  • the dried cornea obtained by the gradient decompression method of this example has a water content of 10 ⁇ 2% and a light transmittance of 84 ⁇ 1%.
  • the surface of the dried cornea is flat and has no visible protrusions or fine folds.
  • the pressure is reduced to the maximum vacuum of the apparatus for a period of time by means of continuous decompression.
  • the artificial cornea that needs to be dried is placed on the support device and placed in a drying oven at 0 ° C ⁇ 30 ° C;
  • the second step is to control the vacuum regulation system and start the continuous decompression operation.
  • the decompression curve is as shown in Fig. 6.
  • the pressure in the closed and dry vessel is continuously decompressed at a constant speed to the maximum vacuum pressure of the device within 12 hours. Kpa;
  • the third step is to dry at 0.5kpa until the corneal moisture content is reached, about 1 hour.
  • the dried cornea obtained by the gradient decompression method of the present embodiment, the dried cornea has a water content of 5 ⁇ 1% and a light transmittance of 85 ⁇ 2%.
  • the surface of the dried cornea is flat and has no visible protrusions or fine folds.
  • this embodiment is another embodiment of continuous decompression.
  • the decompression mode is to continuously depressurize the pressure in the closed and dried container at different speeds to a period of time. The maximum vacuum pressure of the equipment.
  • the artificial cornea that needs to be dried is placed on the support device, and placed in a drying oven at 0 ° C ⁇ 30 ° C Inside;
  • the second step is to control the vacuum regulation system and start continuous decompression operation.
  • the decompression curve is shown in Figure 7.
  • the pressure is reduced from lOlkpa to 70kpa after 4 hours; then the pressure is reduced from 70kpa to 20kpa after 3 hours; Reduce the pressure from 20kpa to 0.5kpa in 3 hours;
  • the third step is to dry at 0.5kpa to reach the corneal moisture content requirement, about 2 hours.
  • the dried cornea obtained by the gradient decompression method of the present embodiment has a moisture content of 12 g of the dried cornea.
  • this embodiment is a third embodiment of continuous decompression.
  • the decompression mode is to continuously decompress the pressure in the closed and dry container at different speeds to a period of time.
  • the maximum vacuum pressure of the equipment is to continuously decompress the pressure in the closed and dry container at different speeds.
  • the vacuum regulating system is controlled, and the pressure reducing operation is continuously decompressed in a constant-speed decompression manner.
  • the decompression curve is as shown in FIG. 8 , and the pressure is continuously reduced from 95 kPa to the system limit pressure of 0.3 kPa in 24 hours;
  • the dried cornea obtained by the gradient decompression method of the example had a moisture content of 5 ⁇ 1% and a light transmittance of 79 ⁇ 3%.
  • the surface of the dried cornea is flat and has no visible protrusions or fine folds.
  • the present invention can satisfy corneal conditions in large quantities.
  • all the influencing factors such as temperature, decompression curve, and drying time are controllable, and the pre-dry state of the cornea can be obtained according to different decellularization methods, and various decompression methods most suitable for the cornea are used. The best combination of the corneal drying quality identity of the same batch or even batches.
  • the dried cornea obtained by the drying method of the present invention has the characteristics of stable performance with respect to the non-dried cornea. It can be cleaned by the simplest method of cryopreservation (such as 0 ⁇ 8 degree cryopreservation in the refrigerator). Its quality and characteristics will not change its performance due to the length of storage or other factors, ensuring that the dried cornea is preserved and transported. After entering the clinical use state, the quality identity can still be guaranteed, and the purpose of preservation and transportation can be achieved.
  • the dry cornea has the necessary conditions for industrialization and marketization as a product, which is beneficial to the market promotion of artificial cornea.
  • tests have shown that the dried cornea obtained by the drying method of the present invention has a mechanical processing property similar to that of a chemical contact lens when the water content is less than 10 to 15%.
  • the biomatrix cornea of the present invention has incomparable biocompatibility with respect to chemical contact lenses.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Materials For Medical Uses (AREA)
  • Drying Of Solid Materials (AREA)

Abstract

A method of drying a decellularized lamellar cornea and a dried decellularized pig lamellar cornea obtained thereby. The drying method comprises first placing the cornea into a vacuum drying chamber; gradually reducing a pressure within the closed drying chamber; and gradually reducing the pressure to a pressure at a set maximum vacuum degree over a time period until a required corneal dryness is reached. The drying method allows a milder corneal drying process, and minimizes damage to a corneal collagen alignment structure during the vacuum drying.

Description

一种脱细胞角膜的干燥方法及脱细胞猪板层干燥角膜 所属领域  Method for drying decellularized cornea and dried cell of acellular pig layer
本发明是涉及用于治疗角膜致盲性眼病的人工角膜的制备方法,具体地是一 种脱细胞角膜的干燥方法及以猪角膜为供体来源的脱细胞板层干燥角膜。 背景技术  The present invention relates to a method for preparing an artificial cornea for treating corneal blinding eye diseases, in particular to a method for drying a decellularized cornea and a decellularized lamellar dried cornea using a porcine cornea as a donor source. Background technique
角膜移植是目前治疗角膜盲的唯一有效的方法, 由于中国角膜供体的严重 缺乏现状, 大大地影响了该手术的大范围推广,但也促使中国在异种异体角膜替 代领域的研究取得了举世瞩目的成就,特别是以猪角膜为供体来源的脱细胞猪板 层角膜的应用成果被国外科学界誉为中国当代五项重大创新之一。  Corneal transplantation is currently the only effective method for treating corneal blindness. Due to the serious lack of status of corneal donors in China, it has greatly affected the wide-scale promotion of this operation, but it has also made China's research in the field of heterogeneous corneal replacement a world-famous The achievements, especially the application of acellular porcine lamellar cornea with porcine cornea as donor source, have been praised by foreign scientific circles as one of the five major innovations in contemporary China.
近十年来,基于猪角膜具有与人角膜高度近似的组织结构、生物物理学特性 和光学特性是角膜替代物的最佳选择的公认结论。国内眼科界学者成功地实现了 将脱细胞处理取得猪板层角膜直接应用于人体的移植,并取得了一定的临床效果。 以猪角膜为材料来源的人工角膜与其它材料人工角膜技术相比,具有材料来源广 泛、 成本低、 处理方法简单、 临床效果好等诸多优势。 国内已有两家公司开发了 以猪角膜为供体来源的人工角膜产品通过中国相关监管部门的市场准入审批应 用于临床, 为角膜病患者带来福音同时, 也带来一个巨大的市场需求。  In the last decade, the porcine cornea has a tissue structure, biophysical properties and optical properties similar to human cornea height, which is the accepted conclusion of the best choice for corneal substitutes. The domestic ophthalmologists have successfully realized the transplantation of the porcine lamellar cornea directly into the human body, and achieved certain clinical effects. The artificial cornea with porcine cornea as the material has many advantages such as wide material source, low cost, simple treatment method and good clinical effect compared with other artificial cornea techniques. Two domestic companies have developed artificial corneal products with porcine cornea as donor source, which has been applied to the clinic through market access approval of relevant Chinese regulatory authorities, bringing good news to patients with corneal diseases and bringing a huge market demand. .
板层角膜是相对于全层结构的角膜而言,仅包括前弹力层和基质层的板层结 构的角膜 (支架)。 包括有三种形态: 未干燥板层支架 (指脱水至原角膜的含水 量)、干燥板层支架和复水板层支架。(见本发明人在先申请第 CN10197144专利)。 目前大量的专利文献以及相关文献中所公开的多种脱细胞猪角膜板层角膜的制 备方法, 以及对其所采用的制备方法而获得的检测数据、动物试验数据以及临床 效果。大都是依据试验室中完成脱细胞处理之后的非干燥角膜状态下取得的。并 且因其制备方法的不同, 其试验数据或临床效果也不尽完全相同。 毋庸置疑, 目 前公开的现有技术中,所称的角膜产品及其应用效果仅仅是建立在非干燥角膜的 试验数据状态上, 还不具备可以在市场上推广使用的条件, 即在生产、 保存、 运 输及使用等市场运营每个环节上保证产品质量同一性和性能稳定性。  The lamellar cornea is a cornea (scaffold) comprising only the lamella structure of the front elastic layer and the matrix layer with respect to the cornea of the full-layer structure. It is available in three forms: unseasoned lamellar scaffold (referred to as water content dehydrated to the original cornea), dry lamellar scaffold and rehydred lamellar scaffold. (See the applicant's prior application No. CN10197144). A large number of patent documents and methods for preparing a variety of acellular porcine corneal lamellar corneas disclosed in the related literature, as well as test data, animal test data, and clinical effects obtained by the preparation method employed therefor. Most of them are obtained according to the non-drying corneal state after completion of the decellularization treatment in the laboratory. And because of the different preparation methods, the test data or clinical effects are not exactly the same. Undoubtedly, in the currently disclosed prior art, the so-called corneal products and their application effects are only based on the test data state of the non-dried cornea, and there is no condition that can be promoted and used in the market, that is, in production and preservation. , product quality and performance stability at every stage of market operations such as transportation and use.
特别是非干燥角膜存在最大的缺陷是极其不容易于保存和运输。在保存和运 输的过程中,非干燥状态的板层角膜的质量及其生物物理特性会因保存条件和运 输条件的变化而随之发生改变, 并且这个变化又是不可预测的。因此医生在临床 时根本无法判定其所使用的人工角膜所能达到的术后效果。据所公布的数据来看, 目前市场上使用此类人工角膜移植术的临床效果统计来看, 即使手术成功, 术后 复明的时间也需长达 3个月至 6个月之久。这种移植结果不仅与人角膜的移植效 果相差甚远, 并且医生也很难在尽可能短的时间内对移植术是否成功、 以及术后 复明效果做出准确的判断,不利于对失败或复明效果差移植术后结果采取尽可能 早的补救。 In particular, the biggest drawback of non-dried corneas is that they are extremely difficult to store and transport. During storage and transportation, the quality and biophysical properties of the non-drying lamellar cornea will be preserved and transported. The change in the conditions of the change changes with it, and this change is unpredictable. Therefore, the doctor cannot judge the postoperative effect that the artificial cornea used can be achieved in the clinic. According to the published data, the clinical effect of using such artificial corneal transplantation on the market is that, even if the operation is successful, the time for postoperative recovery needs to be as long as 3 months to 6 months. This transplantation result is not only far from the transplantation effect of human cornea, but also it is difficult for doctors to make accurate judgments on the success of transplantation and the effect of postoperative recovery in the shortest possible time, which is not conducive to failure or recovery. Poor results After transplantation, the results were taken as soon as possible.
为解决上述问题,目前研究人员提出的方法是对脱细胞之后的角膜进行必要 干燥处理以获得一种易于保存和运输的干燥角膜。但是, 目前提出的诸多可选择 干燥方法均是常规的干燥方式。诸如, 目前已公开的角膜的干燥方式主要包括冷 冻干燥, 甘油脱水, 变性硅胶脱水, 五氧化二磷及无水氯化钙脱水等被广泛地使 用于对医疗器械领域的常规干燥技术。本申请人曾穷尽目前所有常规干燥方法对 人工角膜进行大量的干燥处理试验。通过对干燥前后的人工角膜所有生物物理性 进行比较后发现,任何一种常规的干燥过程都会对人工角膜的生物物理特性产生 一定程度的不利影响。本申请人在对每种干燥方法在干燥过程获得的大量的试验 数据进行研究统计分析后发现,上述常规的干燥方法对人工角膜的不利影响的原 因是其干燥过程过于剧烈。特别是, 人工角膜通过脱细胞处理后, 由于角膜中包 含大量的水分以及细胞去除后存在的间隙,使得胶原支架变得非常松散, 并同时 失去了原来的基质层中胶原排列的支撑力。在这种状态下, 剧烈的干燥过程必然 会使得胶原组织排列发生不规则的改变,从而破坏了原角膜基质层中高度规则的 胶原纤维排列。  In order to solve the above problems, the current researchers have proposed a method of drying the cornea after decellularization to obtain a dry cornea which is easy to store and transport. However, many of the alternative drying methods currently proposed are conventional drying methods. For example, the currently disclosed methods of drying the cornea mainly include freeze-drying, dehydration of glycerin, dehydration of denaturing silica, dehydration of phosphorus pentoxide and dehydration of anhydrous calcium chloride, and are widely used in conventional drying techniques in the field of medical devices. The Applicant has exhausted all of the conventional drying methods to perform extensive drying treatment tests on artificial corneas. By comparing all biophysical properties of the artificial cornea before and after drying, it was found that any conventional drying process would have a certain degree of adverse effect on the biophysical properties of the artificial cornea. The present inventors have conducted research and statistical analysis on a large amount of test data obtained by each drying method in the drying process, and found that the above-mentioned conventional drying method has an adverse effect on the artificial cornea because the drying process is too severe. In particular, after the decellularized treatment of the artificial cornea, the collagen scaffold becomes very loose due to the large amount of water contained in the cornea and the gap existing after the removal of the cells, and at the same time, the supporting force of the collagen arrangement in the original matrix layer is lost. In this state, the violent drying process inevitably causes an irregular change in the arrangement of the collagen tissue, thereby destroying the highly regular arrangement of the collagen fibers in the original corneal stroma.
角膜具有不同与其它一切组织的鲜明特点: 透明。这也是角膜执行其生理功 能最重要的基础。 而角膜的透明度是源于基质层高度规则的胶原纤维结构排列。 同时角膜基质层高度规则的胶原纤维结构排列也是角膜机械弹性的结构基础。大 量的试验证明,上述现有的任何一种常规干燥方法都会不同程度地破坏角膜基质 层的胶原纤维的规则排列,对人工角膜产品的如透明、机械弹性等生物物理特性 产生一定程度的不利影响。 例如, 在专利号为 CN104645415公开了所有常规的 干燥方法,包括真空冻干,真空晾干, 自然晾干,干燥无水氯化钙真空干燥, 30-60 °C 温箱内烘干等。所有这些常规干燥方法中除自然晾干之外, 其它方法都是通过非 自然因素的干涉作用达到缩短干燥时间以及保证干燥效果相同。 目前在研究实践中, 也有使用真空干燥方法对生物材料进行干燥处理。 由于 真空干燥具有温度低, 无过热现象, 水分易于蒸发, 干燥时间短, 以及减少物料 与空气的接触机会, 能避免污染等特点, 是目前使用最为广泛干燥方法。但由于 真空干燥是在一个封闭的环境中通过降低压强实现降低水分的沸点 (沸点干燥) 或者融点 (冷冻干燥), 加快物体中的水分的汽化或升华, 从而达到快速干燥的 目的。依据真空干燥的原理, 沸点干燥属于高温干燥的过程。在干燥过程中物料 中水分在足够的热量作用下使蒸发和沸腾同时进行,尽管在低压状态下降低了水 的沸点,但仍需一定热量保证干燥物体内水达到蒸发和沸腾状态,这个过程显然 是剧烈的。 同时在抽真空快速抽出汽化的蒸汽时在物料周围形成负压状态,在物 料的内外层之间形成有较大的湿度梯度, 所以沸点干燥也是极不均匀的干燥, 直 接用于新鲜角膜的干燥会对角膜胶原纤维排列造成一定的破坏。因此,科研及生 产实践中很少采用沸点干燥方法对角膜进行干燥处理。 The cornea has distinct characteristics that are different from all other tissues: transparent. This is also the most important basis for the cornea to perform its physiological functions. The transparency of the cornea is derived from the highly regular arrangement of collagen fibers in the matrix layer. At the same time, the highly regular arrangement of collagen fibers in the corneal stroma is also the structural basis of the mechanical elasticity of the cornea. A large number of experiments have proved that any of the conventional drying methods described above can damage the regular arrangement of collagen fibers in the corneal stroma layer to a certain extent, and have a certain degree of adverse effect on the biophysical properties of artificial corneal products such as transparency and mechanical elasticity. . For example, all conventional drying methods are disclosed in the patent number CN104645415, including vacuum lyophilization, vacuum drying, natural drying, dry anhydrous calcium chloride vacuum drying, drying in a 30-60 ° C incubator, and the like. In addition to naturally drying in all of these conventional drying methods, other methods achieve the same drying time and the same drying effect by interference of unnatural factors. At present, in the research practice, the biological material is dried by using a vacuum drying method. Because vacuum drying has low temperature, no overheating, easy evaporation of water, short drying time, and reduced contact with materials and air, it can avoid pollution and is the most widely used drying method. However, since vacuum drying is achieved by lowering the pressure by lowering the pressure (dry boiling point) or melting point (freeze drying) in a closed environment, the vaporization or sublimation of moisture in the object is accelerated, thereby achieving rapid drying. According to the principle of vacuum drying, boiling point drying is a process of high temperature drying. During the drying process, the moisture in the material is simultaneously evaporated and boiled under sufficient heat. Although the boiling point of the water is lowered in the low pressure state, a certain amount of heat is required to ensure that the water in the dried object reaches the evaporation and boiling state. It is violent. At the same time, when the vaporized steam is quickly extracted, a negative pressure state is formed around the material, and a large humidity gradient is formed between the inner and outer layers of the material, so the boiling point is also dried very unevenly, and is directly used for drying the fresh cornea. It will cause some damage to the corneal collagen fiber arrangement. Therefore, in the scientific research and production practice, the boiling point drying method is rarely used to dry the cornea.
在升华干燥(冷冻干燥)方法中, 首先将物料水分冻结成固态, 然后在高度 真空下,将其中固态水分直接升华为气态而除去。这种方法没有沸点干燥中如蒸 发和沸腾的高温剧烈反应, 是生物材料中应用较多的干燥方法。然而, 由于这种 干燥方法原理在于在低压条件下降低水的沸点,使组织内的冰晶升华为汽态而除 去, 而冰晶所占据的体积则形成孔状结构。第四军医大学发表的论文《晾干和冻 干去细胞猪角膜基质作为组织工程角膜支架材料的比较》中给出的试验结论显示, 在 TEM观察下,冻干(冷冻干燥)猪角膜基质层的胶原排列紊乱,呈多孔结构, 前弹力表面有嵴状突起, 失去了规则的板层结构。 大量的试验证明, 在角膜脱细 胞处理的过程中, 角膜基质内含水量增大的同时胶原组织呈松解状态时, 角膜板 层间胶原及板层内胶原间距离增大并完全由水分占领。而当其中的流动状态的水 分布不均匀时板层内胶原间距离也因此而不均匀,角膜板层胶原排列结构也会呈 不稳定状态, 当水分在低温状态下固结成冰晶时, 很难保证角膜板层胶原纤维排 列仍保持原有的高度规则性。不难证明的事实是真空冻干的方法对人工角膜的透 明度影响相当大。  In the sublimation drying (freeze drying) method, the moisture of the material is first frozen to a solid state, and then the solid water is directly sublimated into a gaseous state under a high vacuum to be removed. This method does not have a high temperature and violent reaction such as evaporation and boiling in boiling point drying, and is a drying method which is widely used in biological materials. However, since the drying method is based on lowering the boiling point of water under low pressure conditions, the ice crystals in the tissue are sublimated into a vapor state and removed, and the volume occupied by the ice crystals forms a pore-like structure. The conclusions given in the paper "Comparison of dried and lyophilized decellularized porcine corneal stroma as tissue engineering corneal scaffolds" published by the Fourth Military Medical University show that lyophilized (lyophilized) porcine corneal stroma is observed under TEM observation. The collagen is arranged in a disorderly structure with a porous structure, and the front elastic surface has a ridge-like protrusion, which loses the regular slab structure. A large number of experiments have shown that during the process of corneal decellularization, when the water content in the corneal stroma increases and the collagen tissue is released, the distance between the collagen and the collagen in the lamellar layer increases and is completely occupied by water. . When the water distribution in the flowing state is uneven, the distance between the collagen layers in the lamellar layer is also uneven, and the collagen arrangement structure of the corneal lamellar layer is also unstable. When the water is consolidated into ice crystals at a low temperature, it is very It is difficult to ensure that the collagen fiber arrangement of the corneal layer remains the original high degree of regularity. It is not difficult to prove that the vacuum freeze-drying method has a considerable influence on the transparency of the artificial cornea.
专利号为 CN 104188957提出了与其基本相同一种用无菌风干的无非自然因 素影响的自然干燥方法, 即将脱细胞角膜基质平铺于 24孔板培养板中置于超净 台无菌风干 48~72小时。这种自然干燥方法存在的缺陷是干燥时间太长,容易造 成角膜的胶原蛋白变性,从而影响角膜的透明度。并且在所有的干燥时间全程内, 环境的无菌状态的保持的难度相当高。另外,自然晾干的其它条件如温度的控制、 风力的调节等很难控制,干燥程度以及干燥时间很难控制。而自然环境的其它不 可控因素的影响则会造成干燥效果的不相同,甚至同一批次的角膜干燥不均匀而 使干燥效果存在差异, 更无法保证所有批次干燥效果相同。所以目前自然干燥方 法也仅适用于试验室或小批量生产条件,基本上不能应用于大批量的产业化规模 生产。 这也是目前医疗器械产业化领域内基本上无人采用的原因。 Patent No. CN 104188957 proposes a natural drying method which is basically the same as that of a non-natural factor that is sterile and air-dried, that is, the acellular corneal stroma is placed in a 24-well plate culture plate and placed in a clean bench for 48°. 72 hours. The drawback of this natural drying method is that the drying time is too long, which tends to cause collagen denaturation of the cornea, thereby affecting the transparency of the cornea. And throughout all drying time, The maintenance of the sterility of the environment is quite difficult. In addition, other conditions such as temperature control, wind adjustment, etc., which are naturally dried, are difficult to control, and the degree of drying and drying time are difficult to control. However, the influence of other uncontrollable factors in the natural environment will result in different drying effects. Even the corneal drying in the same batch will be uneven and the drying effect will be different, and the drying effect of all batches cannot be guaranteed to be the same. Therefore, the current natural drying method is only applicable to the laboratory or small batch production conditions, and basically cannot be applied to large-scale industrial scale production. This is also the reason why there is basically no adoption in the field of medical device industrialization.
基于人角膜的保存经验, 一些文献中提出使用较多的仍是甘油保存方法。该 方法是将非干燥角膜置于甘油中密封保存。这种方法主要是角膜处于甘油液体中 保存, 在保存过程中进行的逐步脱水的过程。 其缺陷也是显而易见的, 其一, 液 态保存状态不利于运输, 并且甘油在运输过程中, 容易产生爆炸等安全隐患; 其 二,逐步脱水过程很难保证在角膜进入临床使用状态下质量的同一性, 也无法对 角膜移植术进行规范,需医生在临床时依据角膜当时的保存状态做出适应性改变; 其三, 在手术前需要进行清洗, 去除粘在角膜上的甘油, 如果清洗不干净, 容易 在角膜上形成残留物而严重影响手术效果。其四, 非干燥角膜无法对其形状进行 修改加工。 例如, 依据移植角膜的屈光度需求对角膜形状进行修正。  Based on the preservation experience of human cornea, some literatures suggest that more glycerin preservation methods are used. The method is to seal the non-dried cornea in glycerin. This method is mainly a process in which the cornea is stored in a glycerin liquid and is gradually dehydrated during storage. The defects are also obvious. First, the liquid preservation state is not conducive to transportation, and glycerin is prone to explosion and other safety hazards during transportation. Second, the gradual dehydration process is difficult to ensure the quality of the cornea in clinical use. It is also impossible to regulate the corneal transplantation. It is necessary for the doctor to make adaptive changes according to the preservation state of the cornea at the time of clinical use. Third, it is necessary to clean before the operation to remove the glycerin sticking to the cornea. If the cleaning is not clean, It is easy to form residues on the cornea and seriously affect the surgical effect. Fourth, the non-dried cornea cannot modify its shape. For example, the shape of the cornea is corrected based on the diopter requirements of the transplanted cornea.
本申请人在对干燥角膜的大量动物试验以及部分临床试验发现,使用干燥角 膜进行角膜移植时,干燥角膜的透明度以及角膜的形态,特别是角膜的平整度对 角膜移植术的术后效果至关重要。首先,透明度越高移植术后的复明的透明度越 高; 其次, 含水量基本相同干燥角膜可以对移植术的复水操作进行规范, 可以实 现对复水后角膜复水饱和度的有效控制,有利于缩短角膜术后透明的时间;其三, 角膜的平整度,特别是角膜前弹力层的平整越高,越有利于上皮层细胞的贴附与 增殖。不平整的或者表面呈现目视可见的嵴状突起或者细小褶皱的干燥角膜都会 在不同程度上影响了移植术后复明效果。  In the large number of animal tests and some clinical trials on dry cornea, the applicant found that the transparency of the cornea and the morphology of the cornea, especially the smoothness of the cornea, are crucial for the postoperative effect of keratoplasty when the cornea is transplanted with dry cornea. important. First, the higher the transparency, the higher the transparency of the recovery after transplantation. Secondly, the water content is basically the same. The dry cornea can regulate the rehydration operation of the transplant, which can effectively control the rehydration of the cornea after rehydration. It is beneficial to shorten the time of transparency after corneal surgery. Thirdly, the flatness of the cornea, especially the higher the level of the pre-corneal elastic layer, is more conducive to the attachment and proliferation of epithelial cells. Uneven or dry corneas with visually visible verrucous protrusions or fine folds can affect the healing effect after transplantation to varying degrees.
随着以猪脱细胞板层角膜替代人角膜用于治疗角膜盲复明技术的日臻成熟 和发展, 市场上对猪脱细胞板层角膜的需求量极大的提升。因此有必要提出一种 干燥角膜的制备方法,在满足利于保存和运输的条件下, 最大限度保证干燥角膜 产品的质量同一性和性能稳定性的市场属性。 发明内容  With the replacement of human cornea with porcine acellular lamellar cornea for the treatment of corneal blind replication technology, the demand for corneal decellularized lamellar cornea is greatly increased. Therefore, it is necessary to propose a method for preparing a dry cornea, which satisfies the market property of maximizing the quality identity and performance stability of the dried corneal product under conditions suitable for preservation and transportation. Summary of the invention
本发明的目的在于提供一种脱细胞角膜的干燥方法,使得角膜的干燥过程更 加温和, 最大限度地减小在干燥环节对角膜胶原纤维排列结构的破坏,使得干燥 后角膜最大限度地保持有与干燥前角膜基本相同的物理学特性。 The object of the present invention is to provide a method for drying acellular cornea, which makes the cornea drying process more The mildening minimizes the destruction of the corneal collagen fiber alignment structure during the drying process, so that the cornea after drying has the same physical properties as the cornea before drying.
本发明的另一目的在于提供一种脱细胞角膜的干燥方法及其干燥角膜,提高 干燥后角膜的透明度以利于缩短角膜植入术后恢复透明的时间。  Another object of the present invention is to provide a method for drying a decellularized cornea and a dry cornea thereof, which improves the transparency of the cornea after drying to facilitate shortening the time for recovery of transparency after corneal implantation.
本发明的再一目的在于提供一种脱细胞角膜的干燥方法及其干燥角膜,提高 干燥角膜外观形态的平整度,特别是角膜前弹力层的平整度以利于提高角膜植入 后上皮细胞的生长速度和生长质量。  A further object of the present invention is to provide a method for drying acellular cornea and a dry cornea thereof, which improves the flatness of the appearance of the dried cornea, in particular, the flatness of the pre-corneal elastic layer to facilitate the growth of epithelial cells after corneal implantation. Speed and growth quality.
本发明的目的之四在于提供一种脱细胞角膜的干燥方法及其干燥角膜,使之 便于保存和运输,使人工角膜具备市场流通的产品属性。促进人工角膜产品的标 准化、 产业化及市场化发展, 满足人工角膜巨大的市场需求。  A fourth object of the present invention is to provide a method for drying a decellularized cornea and a dried cornea, which are convenient for storage and transportation, and which provide artificial corneal with product properties of market circulation. Promote the standardization, industrialization and market development of artificial corneal products to meet the huge market demand for artificial corneas.
本发明的目的之五在于提供一种脱细胞角膜的干燥方法及其干燥角膜,使之 可以方便地依据需求对角膜进行精确修正加工,特别是对角膜屈光度的加工, 扩 大人工角膜在屈光校正上的应用范围。 本发明的目的是这样实现的,一种脱细胞角膜的干燥方法, 先将欲干燥角膜 放置于承托装置上,放入真空度可调的密闭干燥室内; 通过真空调节系统降低密 闭干燥室内的压力低于大气压力; 其特征在于, 调节密闭干燥室的压力在一时间 段内逐渐减压至设定的最大真空度时的压力,并在设定的最大真空度状态下持续 至达到角膜干燥度的要求。  The fifth object of the present invention is to provide a method for drying acellular cornea and a dry cornea, which can conveniently perform precise correction processing on the cornea according to requirements, in particular, processing corneal diopter, and expanding artificial cornea in refractive correction. The scope of application. The object of the present invention is achieved by a method for drying a decellularized cornea, which is first placed on a support device and placed in a closed drying chamber with adjustable vacuum; and the vacuum drying system is used to reduce the closed drying chamber. The pressure is lower than the atmospheric pressure; and the pressure in the closed drying chamber is gradually reduced to a set maximum pressure during a period of time, and continues to reach the corneal drying under the set maximum vacuum state. Degree requirements.
本发明的工作原理是,在将欲干燥的角膜放入真空度可调的密闭干燥室后, 将真空干燥室内压力设定在一个低于大气压力但高于干燥室最大真空度的压力 上, 并通过调节系统, 将密闭干燥室的压力逐渐调节至设定的最大真空度, 直至 角膜达到其设定的干燥度要求。与现有的真空干燥方法相比较,本发明的真空干 燥的过程变得更加温和, 从而克服了现有的干燥方法干燥过程过于剧烈的缺陷。 因此本发明最大限度地减小了角膜干燥过程中对基质层的胶原规则排列破坏程 度。在相同脱细胞方法的条件下(即排除其它制备过程对角膜的影响的情况下), 采用本发明的干燥方法获得的干燥角膜,其基质层的胶原排列与干燥前基本上没 有进一步的破坏性改变。本发明干燥方法适用于全层角膜和板层角膜的干燥处理。  The working principle of the invention is that after the cornea to be dried is placed in a closed drying chamber with adjustable vacuum degree, the pressure in the vacuum drying chamber is set at a pressure lower than atmospheric pressure but higher than the maximum vacuum of the drying chamber. And through the adjustment system, the pressure of the closed drying chamber is gradually adjusted to the set maximum vacuum until the cornea reaches its set dryness requirement. Compared with the existing vacuum drying method, the vacuum drying process of the present invention becomes gentler, thereby overcoming the drawback that the drying process of the prior drying method is too severe. Therefore, the present invention minimizes the degree of destruction of collagen regular alignment of the matrix layer during corneal drying. Under the conditions of the same decellularization method (ie, excluding the influence of other preparation processes on the cornea), the dried cornea obtained by the drying method of the present invention has substantially no further destructive collagen arrangement of the matrix layer before drying. change. The drying method of the present invention is suitable for the drying treatment of the full-thickness cornea and lamellar cornea.
在本发明较佳实施方式中,所述密闭干燥室内的减压方式为以至少两级自高 向低梯度减压,在每一级的压力梯度上持续一时间段; 最后一级梯度压力再减压 至设定的最大真空度状态。 本较佳实施方式更便于操作, 易于控制。 其中: 在本发明一个可选的例子中, 所述每级梯度的减压范围 10 100 kpa; 其中优 先减压范围为 10~30kpa。 In a preferred embodiment of the present invention, the pressure reduction mode in the closed drying chamber is at least two stages from high to low gradient pressure reduction, and the pressure gradient of each stage lasts for a period of time; stress reliever To the set maximum vacuum state. The preferred embodiment is more convenient to operate and easier to control. Wherein: In an optional example of the present invention, the decompression range of each gradient is 10 100 kpa; wherein the preferential decompression range is 10~30 kPa.
在本发明一个可选的例子中, 每一级的压力梯度上持续时间设定为随压力的 减小而减少。  In an alternative embodiment of the invention, the duration of the pressure gradient for each stage is set to decrease as the pressure decreases.
在本发明一个可选的例子中,压力梯度变化时所述真空调节系统调节前一级 压力挡直接调节至后一级压力挡。  In an alternative embodiment of the invention, the vacuum adjustment system adjusts the previous stage pressure block to adjust directly to the subsequent stage pressure block as the pressure gradient changes.
在本发明另一个可选的例子中,压力梯度变化时所述真空调节系统调节前一 级压力挡逐渐降低到后一级压力挡。  In another alternative embodiment of the invention, the vacuum adjustment system adjusts the previous stage pressure differential to gradually decrease to the next stage pressure differential as the pressure gradient changes.
在本发明另一个可选的例子中, 所述每级减压梯度的持续时间段 0.5 12小 时; 其中优先持续时间段为 0.5 4小时。  In another optional embodiment of the invention, the duration of each stage of the reduced pressure gradient is 0.5 12 hours; wherein the priority duration is 0.54 hours.
本发明的另一个实施方式,所述控制密闭干燥室内的减压方式为在一时间段 内连续减压至设定的最大真空度状态。在连续减压的实施方式中,减压的操作可 以采用自动控制的方式实现。  In another embodiment of the present invention, the method of controlling the pressure reduction in the sealed drying chamber is to continuously reduce the pressure to a set maximum vacuum state for a period of time. In a continuous depressurization embodiment, the operation of the reduced pressure can be achieved by means of automatic control.
在本发明一个可选的例子中, 密闭干燥室内的温度控制在 0°C~30°C内。 在本发明一个可选的例子中,真空调节系统调节密闭干燥室的压力在不大于 24小时内减压至设定的最大真空度时的压力; 其中优先在 6~11小时减压至设定 的最大真空度时的压力。  In an alternative embodiment of the invention, the temperature in the enclosed drying chamber is controlled between 0 ° C and 30 ° C. In an optional example of the present invention, the vacuum adjustment system adjusts the pressure at which the pressure of the closed drying chamber is reduced to a set maximum vacuum within no more than 24 hours; wherein the pressure is preferentially set to 6 to 11 hours. The maximum vacuum when the pressure.
在本发明一个可选的例子中,所述密闭干燥室的压力调节范围为常压至设定 的最大真空度。  In an alternative embodiment of the invention, the pressure regulating range of the closed drying chamber is from atmospheric pressure to a set maximum vacuum.
在本发明一个可选的例子中,所述设定的最大真空度时的压力接近极限真空。 本发明一个可选的实施例中, 所述角膜干燥度依据角膜含水率设定。  In an alternative example of the invention, the set maximum vacuum is at a pressure close to the ultimate vacuum. In an alternative embodiment of the invention, the corneal dryness is set according to the corneal moisture content.
本发明较佳实施例中, 角膜干燥度最佳设定为含水率不大于 20%。 本发明提供的一种脱细胞猪干燥角膜,经过脱细胞处理的猪角膜前弹力层和 基质层构成, 由上述任意一干燥方法获得。 干燥角膜的含水率大于 0%且不大于 20%。 干燥角膜的透光率不低于 70%。 干燥角膜表面平整, 无肉眼可见的嵴状突 起或者细小褶皱。  In a preferred embodiment of the invention, the corneal dryness is optimally set to a moisture content of no greater than 20%. The invention provides a decellularized porcine dry cornea, which comprises a decellularized porcine corneal anterior elastic layer and a matrix layer, and is obtained by any of the above drying methods. The moisture content of the dried cornea is greater than 0% and not greater than 20%. The light transmittance of the dried cornea is not less than 70%. The surface of the dried cornea is flat, with no visible ridges or fine folds visible to the naked eye.
本发明与当前常规的干燥技术相比较效果相当显著。首先,本发明是基于真 空干燥的原理, 因此具有真空干燥温度低, 无过热现象, 水分易于蒸发, 干燥时 间短优点。但是,在本发明通过逐渐减压方式有效地克服了现有的真空干燥方法 中的干燥过于剧烈的缺陷,使得真空干燥的过程变得更加温和。并因此而最大限 度地减小了角膜干燥过程中对基质层的胶原纤维规则排列破坏程度。在相同脱细 胞方法的条件下 (即排除其它制备过程对角膜的影响的情况下), 采用本发明的 干燥方法获得的干燥角膜,其基质层的胶原纤维排列与干燥前基本上没有进一步 的破坏性改变。干燥后角膜最大限度地保持有与干燥前角膜基本相同的生物物理 学特性。试验结果证明,本方法干燥方法获得的干燥角膜与常规的干燥方法获得 的干燥角膜相比, 透明度更高, 表面光滑, 具有极好的肉眼可视的平整度。 The effect of the present invention is quite significant compared to current conventional drying techniques. First of all, the present invention is based on the principle of vacuum drying, so that the vacuum drying temperature is low, there is no overheating, the water is easy to evaporate, and when dry Short advantage. However, in the present invention, the excessively severe drying defects in the conventional vacuum drying method are effectively overcome by the gradual decompression method, so that the vacuum drying process becomes gentler. Therefore, the degree of regular destruction of collagen fibers in the matrix layer during corneal drying is minimized. Under the conditions of the same decellularization method (ie, excluding the influence of other preparation processes on the cornea), the dried cornea obtained by the drying method of the present invention has substantially no further damage of the collagen fibers of the matrix layer before drying. Sexual change. After drying, the cornea is kept to the maximum of the same biophysical properties as the cornea before drying. The test results show that the dried cornea obtained by the drying method of the method has higher transparency and smooth surface than the dried cornea obtained by the conventional drying method, and has excellent flatness visible to the naked eye.
本发明干燥角膜临床效果更为显著: 首先,本发明的干燥角膜在角膜移植术 的过程中,即开始逐渐透明。相对于现有的干燥角膜至少需 3个月的复明期而言, 本发明干燥方法获得的干燥角膜更大大地缩短了角膜植入后恢复透明的时间。其 次,基于本发明干燥角膜的平整度极高,所带来的另一显著的临床效果是术后上 皮细胞贴附和增殖速度快、 效果好。  The clinical effect of the dried cornea of the present invention is more remarkable: First, the dried cornea of the present invention begins to gradually become transparent during the corneal transplantation. The dry cornea obtained by the drying method of the present invention greatly reduces the time for recovery of the cornea after implantation due to the curing period of at least 3 months compared to the existing dry cornea. Secondly, the flatness of the dried cornea based on the present invention is extremely high, and another significant clinical effect is that the postoperative epithelial cells adhere and proliferate quickly and have a good effect.
本发明另一重要的技术效果是,本发明的全部干燥过程在真空密闭环境下进 行, 大大地减少角膜与空气的接触机会, 与自然干燥相比可以有效地避免污染。 因此本发明可以满足大批量制备角膜条件。特别是在本发明中,温度、减压曲线、 干燥时间等所有影响因素可控性,可以依据不同的脱细胞方法取得的角膜的干燥 前状态,采用最适于该角膜的各种减压方式的最佳组合, 从而达到同一批次乃至 多批次的角膜干燥质量同一性。  Another important technical effect of the present invention is that the entire drying process of the present invention is carried out in a vacuum-tight environment, greatly reducing the chance of contact between the cornea and the air, and effectively avoiding contamination as compared with natural drying. Therefore, the present invention can satisfy corneal conditions in large quantities. In particular, in the present invention, all influencing factors such as temperature, decompression curve, and drying time are controllable, and the pre-dry state of the cornea obtained by different decellularization methods can be used, and various decompression methods most suitable for the cornea are used. The best combination of the corneal drying quality identity of the same batch or even batches.
本发明干燥方法获得的干燥角膜相对于非干燥角膜而言,具有性能稳定的特 点。 可以通过最简单的低温保存方法, (例如冰箱内的 0~8度低温保存) 其质量 及特性不会因保存时间的长短或其它因素而使其性能发生改变,保证干燥角膜在 通过保存和运输后进入临床使用状态下, 仍能保证质量的同一性, 实现便于保存 和运输目的。使得干燥角膜具有了作为一种产品的产业化及市场化必要条件,有 利于人工角膜的市场推广。  The dried cornea obtained by the drying method of the present invention has characteristics of stable performance with respect to the non-dried cornea. It can be cleaned by the simplest method of cryopreservation (such as 0~8 degree cryopreservation in the refrigerator). Its quality and characteristics will not change its performance due to the length of storage or other factors, ensuring that the dried cornea is preserved and transported. After entering the clinical use state, the quality identity can still be guaranteed, and the purpose of preservation and transportation can be achieved. The dry cornea has the necessary conditions for industrialization and marketization as a product, which is beneficial to the market of artificial cornea.
试验证明本发明干燥方法获得的干燥角膜在含水率低于 10~15%时具有类似 化学接触镜的机械加工性能。可以方便地依据需求通过对角膜形状进行精确加工, 达到角膜植移的特殊需求。特别是对干燥角膜屈光度的加工, 从而实现了人工角 膜在屈光校正方面的应用。而本发明生物基质角膜相对于化学接触镜而言具有不 可比拟的生物兼容性。 附图说明 Tests have shown that the dried cornea obtained by the drying method of the present invention has a mechanical processing property similar to that of a chemical contact lens when the water content is less than 10 to 15%. It is convenient to accurately process the shape of the cornea according to the requirements to achieve the special needs of corneal grafting. In particular, the processing of dry corneal diopter, the application of artificial cornea in refractive correction. The biomatrix cornea of the present invention has incomparable biocompatibility with respect to chemical contact lenses. DRAWINGS
下面结合附图对本发明及其具体实施方式及其效果作简单地介绍,下面的附 图仅仅是选择本发明的一些具体试验例说明, 而非本发明的全部。  The invention and its specific embodiments and their effects are briefly described below with reference to the accompanying drawings, which are merely illustrative of some specific experimental examples of the invention, and not all of the invention.
图 1 本发明梯度减压的第一种实施例; Figure 1 shows a first embodiment of the gradient decompression of the present invention;
图 2本发明梯度减压的第二种实施例; Figure 2 is a second embodiment of the gradient decompression of the present invention;
图 3 本发明梯度减压的第三种实施例; Figure 3 is a third embodiment of the gradient decompression of the present invention;
图 4本发明梯度减压的第四种实施例; Figure 4 is a fourth embodiment of the gradient decompression of the present invention;
图 5本发明梯度减压的第五种实施例; Figure 5 is a fifth embodiment of the gradient decompression of the present invention;
图 6 本发明连续减压的第一种实施例; Figure 6 is a first embodiment of continuous decompression of the present invention;
图 7本发明连续减压的第二种实施例; Figure 7 is a second embodiment of the continuous decompression of the present invention;
图 8本发明连续减压的第三种实施例; Figure 8 is a third embodiment of the continuous decompression of the present invention;
图 9 本发明板层干燥角膜的电镜下超微结构; Figure 9 Ultrastructural ultrastructure of the lamellar dried cornea of the present invention;
图 10 本发明板层干燥角膜电镜下超微结构; Figure 10 is an ultrastructure of the lamellar dry corneal electron microscope of the present invention;
图 11 本发明板层干燥角膜透明度照片; Figure 11 is a photograph of the dried corneal transparency of the ply of the present invention;
图 12本发明板层干燥角膜移植术后 3天照片; Figure 12 is a photograph of a 3-day postoperative lamellar keratoplasty of the present invention;
图 13 本发明板层干燥角膜移植术后 2个月照片。 具体实施方式 Figure 13 Photograph of the 2 months after lamellar keratoplasty of the present invention. detailed description
本发明提供了一种脱细胞角膜的干燥方法,先将欲干燥角膜放置于承托装置 上, 放入真空度可调的密闭干燥室内; 如图 1至图 7所示, 通过真空调节系统将 密闭干燥室内的压力在一时间段内减压至设定的最大真空度时的压力,并在设定 的最大真空度状态下持续至达到角膜干燥度的要求, 从而获得干燥角膜。  The invention provides a method for drying a decellularized cornea, which is first placed on a supporting device and placed in a closed drying chamber with adjustable vacuum; as shown in FIG. 1 to FIG. 7, the vacuum regulating system is adopted. The pressure in the closed drying chamber is depressurized to a set maximum vacuum degree for a period of time, and continues to reach the requirement of corneal dryness under the set maximum vacuum state, thereby obtaining a dried cornea.
本发明的干燥方法是基于真空干燥的原理, 因此具有真空干燥温度低,无过 热现象, 水分易于蒸发, 干燥时间短的优点。 同时, 由于本发明采用通过在一时 间段内逐步减压的方式,有效地克服了现有真空干燥直接将压力调至最大真空度 致使干燥的过程过于剧烈的缺陷。本发明使真空干燥的过程变得更加温和, 并因 此而最大限度地减小了角膜干燥过程中对基质层的胶原纤维规则排列破坏程度。 在相同脱细胞方法的条件下 (即排除其它制备过程对角膜的影响的情况下), 采 用本发明的干燥方法获得的干燥角膜,其基质层的胶原纤维排列与干燥前基本上 没有破坏性改变,干燥后角膜最大限度地保持有与干燥前新鲜角膜基本相近的生 物物理学特性。 The drying method of the present invention is based on the principle of vacuum drying, and therefore has the advantages of low vacuum drying temperature, no overheating, easy evaporation of water, and short drying time. At the same time, since the present invention adopts a method of gradually depressurizing by a period of time, the existing vacuum drying is effectively overcome to directly adjust the pressure to the maximum degree of vacuum, thereby causing the drying process to be too severe. The present invention makes the process of vacuum drying more gentle, and thus minimizes the degree of regular destruction of collagen fibers in the matrix layer during corneal drying. Under the conditions of the same decellularization method (ie, excluding the influence of other preparation processes on the cornea), the dried cornea obtained by the drying method of the present invention, the collagen fibers of the matrix layer are arranged and dried substantially before drying. There is no destructive change, and the cornea is kept to a maximum of biophysical properties that are substantially similar to the fresh cornea before drying.
采用本发明干燥方法获得的干燥角膜,干燥角膜的含水率不高于 20%。透光 率不低于 70%。 干燥角膜表面平整, 无肉眼可见的嵴状突起或者细小褶皱。  The dried cornea obtained by the drying method of the present invention has a moisture content of the dried cornea of not more than 20%. The light transmittance is not less than 70%. The surface of the dried cornea is flat, with no visible protrusions or fine folds visible to the naked eye.
采用本发明干燥方法获得的干燥角膜临床效果显著: 首先,干燥角膜在角膜 移植术的过程中, 即开始逐渐透明。相对于现有的人工角膜至少需 3个月的透明 期而言,本发明干燥方法获得的干燥角膜更大大地缩短了角膜植入后实现透明的 时间。其次, 基于本发明干燥角膜的平整度极高, 所带来的另一显著的临床效果 是术后上皮细胞贴附和增殖速度快效果好。  The clinical effect of the dried cornea obtained by the drying method of the present invention is remarkable: First, the dried cornea begins to gradually become transparent during the corneal transplantation. The dry cornea obtained by the drying method of the present invention greatly shortens the time for achieving transparency after corneal implantation, compared to the existing artificial cornea requiring a clear period of at least 3 months. Secondly, based on the extremely high flatness of the dried cornea of the present invention, another significant clinical effect is that the postoperative epithelial cell attachment and proliferation rate is fast.
如图 9至图 10所示, 为采用本发明干燥方法获得的干燥人工角膜的超微结 构及外观图片。 由图 9至图 10所示的电镜下干燥角膜结构可以看出, 本发明干 燥后角膜最大限度地保持有排列规则的胶原组织超微结构, 结构破坏少,胶原纤 维间的平均间隙均匀 (25 ± 10nm)。  As shown in Figs. 9 to 10, the ultrastructure and appearance of the dried artificial cornea obtained by the drying method of the present invention are shown. It can be seen from the dry corneal structure under the electron microscope shown in FIG. 9 to FIG. 10 that the cornea of the present invention retains the fine structure of the collagen tissue at a maximum, and the structural damage is small, and the average gap between the collagen fibers is uniform (25). ± 10nm).
如图 11所示, 本发明的干燥角膜透明度极高, 表面光滑, 具有极好的肉眼 可视的平整度。 经动物实验, 其性能与人的角膜最接近。  As shown in Fig. 11, the dried cornea of the present invention has an extremely high transparency and a smooth surface, and has excellent flatness which is visually visible to the naked eye. Through animal experiments, its performance is closest to that of human cornea.
图 12、图 13所示为本实施例 1所示的干燥角膜在人角膜移植术后 3天和 2 个月的照片。 从图 11、 图 12术后效果照片可以看出, 本发明的干燥角膜的在术 后 3天即已经呈透明状态, 角膜上皮基本修复, 未见明显排斥反应, 术后 2个 月角膜完全恢复透明, 无新生血管长入, 未见排斥反应。  Fig. 12 and Fig. 13 are photographs showing the dry cornea shown in Example 1 at 3 and 2 months after human corneal transplantation. It can be seen from the postoperative effect photographs of Fig. 11 and Fig. 12 that the dried cornea of the present invention has been in a transparent state 3 days after the operation, the corneal epithelium is basically repaired, no obvious rejection reaction is observed, and the cornea is completely recovered 2 months after the operation. Transparent, no neovascularization, no rejection.
在本发明中, 密闭干燥室内的温度控制在 0°C~30°C内。 密闭干燥室内的压 力范围为常压至设定的最大真空度。所述设定的最大真空度可以是设定的最大真 空度。由于每个密闭干燥室设备的不同,设备所能达到的最大真空度也会有差异, 在本发明中, 设定的最大真空度时的压力接近极限真空。  In the present invention, the temperature in the closed drying chamber is controlled within a range of 0 ° C to 30 ° C. The pressure in the closed drying chamber ranges from atmospheric pressure to the set maximum vacuum. The set maximum vacuum may be the set maximum vacuum. The maximum vacuum that can be achieved by the equipment varies depending on the equipment of each closed drying chamber. In the present invention, the pressure at the set maximum vacuum is close to the ultimate vacuum.
本发明中, 所述压力是指真空调节系统调节密闭干燥室需要达到的压力值, 并非密闭干燥室内的实测压力值。  In the present invention, the pressure refers to a pressure value that the vacuum regulating system needs to adjust to adjust the closed drying chamber, and is not the measured pressure value in the closed drying chamber.
下面通过几个具体实施例来更为详细地说明本发明。  The invention will now be described in more detail by way of several specific embodiments.
实施例 1 Example 1
在本实施例中, 如图 1所示,密闭干燥室内的减压方式为以至少两级自高向 低梯度减压,在每一级的压力梯度上持续一时间段; 最后一级梯度压力再减压至 最大真空度状态。 每级梯度的减压值为 10~50kpa。 每级减压梯度的持续时间段为 30 分钟〜 4 小时。 In this embodiment, as shown in FIG. 1, the decompression mode in the closed drying chamber is decompressed from a high to low gradient in at least two stages, and continues for a period of time on the pressure gradient of each stage; Then depressurize to the maximum vacuum state. The decompression value of each gradient is 10~50kpa. The duration of each stage of the decompression gradient is 30 minutes to 4 hours.
如图 1所示,在本实施例中,压力梯度变化时真空调节系统调节前一级压力 挡瞬时降低到后一级压力挡。  As shown in Fig. 1, in the present embodiment, when the pressure gradient changes, the vacuum regulating system adjusts the first stage pressure stop to instantaneously decrease to the next stage pressure block.
本实施例的干燥方法具体步骤如下:  The specific steps of the drying method of this embodiment are as follows:
第一步, 将需要干燥的人工角膜置于承托装置上, 放入 0°C~30°C的真空干 燥箱内;  In the first step, the artificial cornea that needs to be dried is placed on the support device and placed in a vacuum drying oven at 0 ° C to 30 ° C;
第二步, 控制真空调节系统, 开始梯度减压操作, 压力控制的减压曲线如图 1所示,减压梯度为 80kpa、 60kpa、 40kpa、 20kpa, 持续时间分别为 2h、 2h、 2h、 lh;  The second step is to control the vacuum regulation system and start the gradient decompression operation. The pressure control curve is shown in Figure 1. The decompression gradient is 80kpa, 60kpa, 40kpa, 20kpa, and the duration is 2h, 2h, 2h, lh respectively. ;
第三步, 继续减压至设备最大真空度, 在一个具体的例子中, 该设备最大真 空度为 0.5kpa, 然后保持至人工角膜完全干燥。 在如图 1所示的具体例子中, 在 设备最大真空度状态下, 持续时间大约为 1小时。  In the third step, the pressure is reduced to the maximum vacuum of the device. In a specific example, the maximum vacuum of the device is 0.5 kPa, and then the artificial cornea is completely dried. In the specific example shown in Fig. 1, the duration is about 1 hour in the maximum vacuum state of the device.
在本实施例中,经过多个梯度等级, 大约 7个小时左右将压力逐步降低至设 备最大真空度,然后在最大真空度下持续大约 1小时后达到角膜干燥要求。与现 有直接进入最大真空环境中进行干燥的方法相比,本实施例多梯度减压的方式干 燥过程更为温和,因而最大限度地减小了角膜干燥过程中对基质层的胶原纤维规 则排列的破坏,从而干燥后的干燥角膜产品能够保持较好的透明度和外观平整性。 另外,本实施例低温梯度减压真空干燥的方法与自然晾干相比,时间大大的缩短, 有效减少了角膜蛋白变性,在保持角膜透明度的同时, 也保证了角膜产品的一致 性。  In this embodiment, the pressure is gradually reduced to a maximum vacuum of the apparatus over a period of about 7 hours through a plurality of gradient levels, and then the corneal drying requirement is reached after a maximum vacuum of about 1 hour. Compared with the existing method of directly entering the maximum vacuum environment, the multi-gradient decompression method of the present embodiment has a milder drying process, thereby minimizing the regular arrangement of the collagen fibers in the matrix layer during the corneal drying process. The damage, so that the dried corneal product after drying can maintain good transparency and appearance flatness. In addition, the method of the low-temperature gradient vacuum drying method of the present embodiment greatly shortens the time compared with the natural drying, effectively reduces the denaturation of the corneal protein, and maintains the transparency of the cornea while ensuring the consistency of the corneal product.
采用本实施例的梯度减压方式获得的干燥角膜, 干燥角膜的含水率为 10士 2% , 透光率 90 ±2%。 干燥角膜表面平整, 无肉眼可见的嵴状突起或者细小褶 皱, 如图 11所示。 实施例 2  The dried cornea obtained by the gradient decompression method of the present embodiment has a moisture content of 10 ± 2% and a light transmittance of 90 ± 2%. The surface of the dried cornea is flat, with no visible protrusions or fine folds as shown in Figure 11. Example 2
如图 2所示, 在本实施例中, 采用梯度减压的方式, 通过两个梯级将压力从 60kpa降低到设备最大真空度 0.3kpa。 如图 2所示, 压力梯度变化时真空调节系 统调节前一级压力挡瞬时调节到后一级压力挡。  As shown in Fig. 2, in the present embodiment, the gradient is used to reduce the pressure from 60 kPa to the maximum vacuum of 0.3 kpa through two steps. As shown in Figure 2, when the pressure gradient changes, the vacuum adjustment system adjusts the previous stage pressure block to instantaneously adjust to the next stage pressure block.
在本实施例中, 每一级的压力梯度上持续时间设定为随压力的减小而减少。 本实施例的干燥步骤如下: In the present embodiment, the duration of the pressure gradient for each stage is set to decrease as the pressure decreases. The drying steps of this embodiment are as follows:
第一步, 将需要干燥的人工角膜置于承托装置上, 放入 0°C~30°C的真空干 燥箱内;  In the first step, the artificial cornea that needs to be dried is placed on the support device and placed in a vacuum drying oven at 0 ° C to 30 ° C;
第二步, 控制真空调节系统, 开始梯度减压操作, 减压曲线如图 2所示, 减 压梯度为 60kpa、 30kpa, 持续时间分别为 4h、 4h; The second step is to control the vacuum regulation system and start the gradient decompression operation. The decompression curve is shown in Figure 2. The decompression gradient is 60kpa and 30kpa, and the duration is 4h and 4h respectively .
第三步,继续减压至设备最大真空度 0.3kpa,然后保持至人工角膜完全干燥。 持续时间大约为 1小时。  In the third step, continue to decompress until the maximum vacuum of the device is 0.3kpa, and then keep until the artificial cornea is completely dry. The duration is approximately 1 hour.
在本实施例中,经过 2个梯度等级, 大约 8个小时左右将压力逐步降低至设 备最大真空度, 然后在最大真空度下持续大约 1小时后达到角膜干燥要求。  In the present embodiment, after two gradient levels, the pressure is gradually reduced to about the maximum vacuum of the apparatus for about 8 hours, and then the corneal drying requirement is reached after the maximum vacuum for about one hour.
采用本实施例的梯度减压方式获得的干燥角膜, 干燥角膜的含水率为 18士 2% , 透光率 82±2%。 干燥角膜表面平整, 无肉眼可见的嵴状突起或者细小褶 皱。 实施例 3  With the dried cornea obtained by the gradient decompression method of this example, the dried cornea has a water content of 18 ± 2% and a light transmittance of 82 ± 2%. The surface of the dried cornea is flat and has no visible protrusions or fine folds. Example 3
如图所 3, 在本实施例中, 采用梯度减压的方式, 通过 9 个梯级将压力从 lOlkpa降低到设备最大真空度 0.3kpa。 如图 3所示, 压力梯度变化时真空调节 系统调节前一级压力挡瞬时降低到后一级压力挡。每一级减压的压力梯度非均等 分布。  As shown in Fig. 3, in the present embodiment, the pressure is reduced from lOlkpa to a maximum vacuum of 0.3 kpa through nine steps using a gradient decompression method. As shown in Figure 3, when the pressure gradient changes, the vacuum adjustment system adjusts the first stage pressure block to instantaneously lower to the next stage pressure block. The pressure gradient of each stage of decompression is not evenly distributed.
本实施例的干燥步骤如下:  The drying steps of this embodiment are as follows:
第一步, 将需要干燥的人工角膜置于承托装置上, 放入 0°C~30°C的干燥箱 内;  In the first step, the artificial cornea that needs to be dried is placed on the support device and placed in a drying oven at 0 ° C ~ 30 ° C;
第二步, 控制真空调节系统, 开始梯度减压操作, 减压曲线如图 3所示, 减 压梯度为 85kpa、 70 kpa、 60 kpa、 45 kpa、 35kpa、 25 kpa、 15 kpa, 持续时间分 别为 2h、 2h、 2h、 1.5h、 1.5h、 lh、 lh;  The second step is to control the vacuum regulation system and start the gradient decompression operation. The decompression curve is shown in Figure 3. The decompression gradients are 85kpa, 70kpa, 60kpa, 45kpa, 35kpa, 25kpa, 15kpa, respectively. 2h, 2h, 2h, 1.5h, 1.5h, lh, lh;
第三步,继续减压至设备最大真空度 0.3kpa,然后保持至人工角膜完全干燥。 持续时间大约为 1小时。  In the third step, continue to decompress until the maximum vacuum of the device is 0.3kpa, and then keep until the artificial cornea is completely dry. The duration is approximately 1 hour.
在本实施例中, 经过 7个梯度等级, 大约 11个小时左右将压力逐步降低至 设备最大真空度, 然后在最大真空度下持续大约 1小时后达到角膜干燥要求。  In this embodiment, after 7 gradient levels, the pressure is gradually reduced to about the maximum vacuum of the apparatus for about 11 hours, and then the corneal drying requirement is reached after about 1 hour at the maximum vacuum.
采用本实施例的梯度减压方式获得的干燥角膜, 干燥角膜的含水率为 5士 0. 5% , 透光率 85 ±2%。 干燥角膜表面平整, 无肉眼可见的嵴状突起或者细小 褶皱。 实施例 4 The dried cornea obtained by the gradient decompression method of the present embodiment has a moisture content of 5 ± 0.5% and a light transmittance of 85 ± 2%. Dry corneal surface is flat, no macroscopically visible ridges or small Wrinkles. Example 4
如图所 4所示, 在本实施例中, 采用梯度减压的方式, 通过 4个梯级将压力 从 50kpa降低到设备最大真空度 0.2kpa。如图 4所示, 压力梯度变化时真空调节 系统调节前一级压力挡瞬时降低到后一级压力挡。每一级减压的压力梯度非均等 分布。  As shown in Fig. 4, in the present embodiment, the pressure is reduced from 50 kPa to the maximum vacuum of the device by 0.2 kPa by means of gradient decompression. As shown in Figure 4, when the pressure gradient changes, the vacuum adjustment system adjusts the first stage pressure block to instantaneously lower to the next stage pressure block. The pressure gradient of each stage of decompression is not evenly distributed.
本实施例的干燥步骤如下:  The drying steps of this embodiment are as follows:
第一步, 将需要干燥的人工角膜置于承托装置上, 放入 0°C~30°C的干燥箱 内;  In the first step, the artificial cornea that needs to be dried is placed on the support device and placed in a drying oven at 0 ° C ~ 30 ° C;
第二步, 控制真空调节系统, 开始梯度减压操作, 减压曲线如图 4所示, 减 压梯度为 50kpa、 30kpa、 15 kpa, 持续时间分别为 3h、 2h、 lh,  The second step is to control the vacuum regulation system and start the gradient decompression operation. The decompression curve is shown in Figure 4. The decompression gradient is 50kpa, 30kpa, 15kpa, and the duration is 3h, 2h, lh, respectively.
第三步,继续减压至设备最大真空度 0.2kpa,然后保持至人工角膜完全干燥。 持续时间大约为 1小时。  In the third step, continue to decompress to a maximum vacuum of 0.2kpa, and then keep the artificial cornea completely dry. The duration is approximately 1 hour.
在本实施例中,经过 3个梯度等级, 大约 6个小时左右将压力逐步降低至设 备最大真空度, 然后在最大真空度下持续大约 1小时后达到角膜干燥要求。  In the present embodiment, after three gradient levels, the pressure is gradually lowered to about the maximum vacuum of the apparatus for about 6 hours, and then the corneal drying requirement is reached after the maximum vacuum for about one hour.
采用本实施例的梯度减压方式获得的干燥角膜, 干燥角膜的含水率为 18士 2% , 透光率 84 ±2%。 干燥角膜表面平整, 无肉眼可见的嵴状突起或者细小褶 皱。 实施例 5  The dried cornea obtained by the gradient decompression method of the present embodiment has a moisture content of 18 ± 2% and a light transmittance of 84 ± 2%. The surface of the dried cornea is flat and has no visible protrusions or fine folds. Example 5
如图所 5所示, 在本实施例中, 采用梯度减压的方式, 通过 5个梯级将压力 从 80kpa降低到设备最大真空度 0.5kpa。  As shown in Fig. 5, in the present embodiment, the gradient pressure is reduced by 5 steps to reduce the pressure from 80 kPa to the maximum vacuum of the device of 0.5 kPa.
如图 5所示,在本实施例中,压力梯度变化时所述真空调节系统调节前一级 压力挡逐渐降低到后一级压力挡。  As shown in Fig. 5, in the present embodiment, when the pressure gradient changes, the vacuum regulating system adjusts the pressure of the previous stage to gradually decrease to the pressure of the latter stage.
本实施例的干燥步骤如下:  The drying steps of this embodiment are as follows:
第一步, 将需要干燥的人工角膜置于承托装置上, 放入 0°C~30°C的干燥箱 内;  In the first step, the artificial cornea that needs to be dried is placed on the support device and placed in a drying oven at 0 ° C ~ 30 ° C;
第二步, 控制真空调节系统, 开始梯度减压操作, 减压曲线如图 5所示, 减 压梯度为: 在 80kpa保持 2h; The second step is to control the vacuum regulation system and start the gradient decompression operation. The decompression curve is shown in Figure 5. The decompression gradient is: Maintain 2h at 80kpa;
80kpa经 lh逐渐减压至 60kpa, 在 60kpa保持 lh;  80kpa gradually reduced pressure to 60kpa after lh, and maintained lh at 60kpa;
60kpa经 lh逐渐减压至 40kpa, 在 40kpa保持 lh;  60kpa gradually reduced pressure to 40kpa after lh, and maintained lh at 40kpa;
40kpa经 lh逐渐减压至 20kpa, 在 20kpa保持 lh;  40kpa gradually depressurizes to 20kpa after lh, and maintains lh at 20kpa;
第三步, 20kpa经 lh逐渐减压至设备最大真空度 0.5kpa; 然后在 0.5kpa保 持至人工角膜完全干燥。 持续时间大约为 1小时。 In the third step, 20kpa is gradually decompressed to a maximum vacuum of 0.5kpa after lh ; then it is kept at 0.5kpa until the artificial cornea is completely dry. The duration is approximately 1 hour.
采用本实施例的梯度减压方式获得的干燥角膜, 干燥角膜的含水率为 10士 2% , 透光率 84± 1%。 干燥角膜表面平整, 无肉眼可见的嵴状突起或者细小褶 皱。 实施例 6  The dried cornea obtained by the gradient decompression method of this example has a water content of 10 ± 2% and a light transmittance of 84 ± 1%. The surface of the dried cornea is flat and has no visible protrusions or fine folds. Example 6
如图 6所示, 在本实施例中, 采用连续减压的方式, 在一时间段内将压力降 至设备最大真空度。  As shown in Fig. 6, in the present embodiment, the pressure is reduced to the maximum vacuum of the apparatus for a period of time by means of continuous decompression.
本实施例的干燥步骤如下:  The drying steps of this embodiment are as follows:
第一步, 将需要干燥的人工角膜置于承托装置上, 放入 0°C~30°C的干燥箱 内;  In the first step, the artificial cornea that needs to be dried is placed on the support device and placed in a drying oven at 0 ° C ~ 30 ° C;
第二步, 控制真空调节系统, 开始连续减压操作, 减压曲线如图 6所示, 在 12个小时内将密闭干燥容器内的压力以恒定的速度连续减压到设备最大真空 度压力 0.5kpa;  The second step is to control the vacuum regulation system and start the continuous decompression operation. The decompression curve is as shown in Fig. 6. The pressure in the closed and dry vessel is continuously decompressed at a constant speed to the maximum vacuum pressure of the device within 12 hours. Kpa;
第三步,在 0.5kpa状态下干燥至达到角膜含水率要求,大约 1个小时左右。 采用本实施例的梯度减压方式获得的干燥角膜, 干燥角膜的含水率为 5士 1% , 透光率 85 ±2%。 干燥角膜表面平整, 无肉眼可见的嵴状突起或者细小褶 皱。 实施例 7  The third step is to dry at 0.5kpa until the corneal moisture content is reached, about 1 hour. With the dried cornea obtained by the gradient decompression method of the present embodiment, the dried cornea has a water content of 5 ± 1% and a light transmittance of 85 ± 2%. The surface of the dried cornea is flat and has no visible protrusions or fine folds. Example 7
如图 7所示, 本实施例为连续减压的另一种实施方式, 在本实施例中, 减压 方式为在一时间段内将密闭干燥容器内的压力以不同的速度连续减压到设备最 大真空度压力。  As shown in FIG. 7, this embodiment is another embodiment of continuous decompression. In this embodiment, the decompression mode is to continuously depressurize the pressure in the closed and dried container at different speeds to a period of time. The maximum vacuum pressure of the equipment.
本实施例的干燥步骤如下:  The drying steps of this embodiment are as follows:
第一步, 将需要干燥的人工角膜置于承托装置上, 放入 0°C~30°C的干燥箱 内; In the first step, the artificial cornea that needs to be dried is placed on the support device, and placed in a drying oven at 0 ° C ~ 30 ° C Inside;
第二步,控制真空调节系统,开始连续减压操作,减压曲线如图 7所示, 先 经过 4个小时将压力从 lOlkpa减至 70kpa;再经 3小时将压力从 70kpa减至 20kpa; 然后 3个小时将压力从 20kpa减至 0.5kpa;  The second step is to control the vacuum regulation system and start continuous decompression operation. The decompression curve is shown in Figure 7. The pressure is reduced from lOlkpa to 70kpa after 4 hours; then the pressure is reduced from 70kpa to 20kpa after 3 hours; Reduce the pressure from 20kpa to 0.5kpa in 3 hours;
第三步,在 0.5kpa状态下干燥至达到角膜含水率要求,大约 2个小时左右。 采用本实施例的梯度减压方式获得的干燥角膜, 干燥角膜的含水率为 12士 The third step is to dry at 0.5kpa to reach the corneal moisture content requirement, about 2 hours. The dried cornea obtained by the gradient decompression method of the present embodiment has a moisture content of 12 g of the dried cornea.
1% , 透光率 85 ± 3%。 干燥角膜表面平整, 无肉眼可见的嵴状突起或者细小褶 皱。 实施例 8 1%, light transmittance 85 ± 3%. The surface of the dried cornea is flat and has no visible protrusions or fine folds. Example 8
如图 8所示, 本实施例为连续减压的第三种实施方式, 在本实施例中, 减压 方式为在一时间段内将密闭干燥容器内的压力以不同的速度连续减压到设备最 大真空度压力。  As shown in FIG. 8, this embodiment is a third embodiment of continuous decompression. In this embodiment, the decompression mode is to continuously decompress the pressure in the closed and dry container at different speeds to a period of time. The maximum vacuum pressure of the equipment.
本实施例 8控制真空调节系统, 以均速减压的方式连续减压操作,减压曲线 如图 8所示, 在 24小时内将压力从 95kpa连续减压至系统极限压力 0.3kpa; 采用本实施例的梯度减压方式获得的干燥角膜, 干燥角膜的含水率为 5士 1% , 透光率 79 ± 3%。 干燥角膜表面平整, 无肉眼可见的嵴状突起或者细小褶 皱。  In the eighth embodiment, the vacuum regulating system is controlled, and the pressure reducing operation is continuously decompressed in a constant-speed decompression manner. The decompression curve is as shown in FIG. 8 , and the pressure is continuously reduced from 95 kPa to the system limit pressure of 0.3 kPa in 24 hours; The dried cornea obtained by the gradient decompression method of the example had a moisture content of 5 ± 1% and a light transmittance of 79 ± 3%. The surface of the dried cornea is flat and has no visible protrusions or fine folds.
采用本发明的上述干燥方法, 由于全部干燥过程在真空密闭环境下进行, 大 大地减少角膜与空气的接触机会, 与自然干燥相比可以有效地避免污染。因此本 发明可以满足大批量制备角膜条件。 特别是在本发明中, 温度、 减压曲线、 干燥 时间等所有影响因素可控性,可以依据不同的脱细胞方法取得的角膜的干燥前状 态,采用最适于该角膜的各种减压方式的最佳组合, 从而达到同一批次乃至多批 次的角膜干燥质量同一性。  According to the above drying method of the present invention, since the entire drying process is carried out in a vacuum-tight environment, the contact chance of the cornea and the air is greatly reduced, and contamination can be effectively prevented as compared with natural drying. Therefore, the present invention can satisfy corneal conditions in large quantities. In particular, in the present invention, all the influencing factors such as temperature, decompression curve, and drying time are controllable, and the pre-dry state of the cornea can be obtained according to different decellularization methods, and various decompression methods most suitable for the cornea are used. The best combination of the corneal drying quality identity of the same batch or even batches.
本发明干燥方法获得的干燥角膜相对于非干燥角膜而言,具有性能稳定的特 点。 可以通过最简单的低温保存方法, (例如冰箱内的 0~8度低温保存) 其质量 及特性不会因保存时间的长短或其它因素而使其性能发生改变,保证干燥角膜在 通过保存和运输后进入临床使用状态下, 仍能保证质量的同一性, 实现便于保存 和运输目的。使得干燥角膜具有了作为一种产品的产业化及市场化必要条件,有 利于人工角膜的市场推广。 另外, 试验证明本发明干燥方法获得的干燥角膜在含水率低于 10~15%时具 有类似化学接触镜的机械加工性能。可以方便地依据需求通过对角膜形状进行精 确加工, 达到角膜植移的特殊需求。特别是对干燥角膜屈光度的加工, 从而实现 了人工角膜在屈光校正方面的应用。而本发明生物基质角膜相对于化学接触镜而 言具有不可比拟的生物兼容性。 The dried cornea obtained by the drying method of the present invention has the characteristics of stable performance with respect to the non-dried cornea. It can be cleaned by the simplest method of cryopreservation (such as 0~8 degree cryopreservation in the refrigerator). Its quality and characteristics will not change its performance due to the length of storage or other factors, ensuring that the dried cornea is preserved and transported. After entering the clinical use state, the quality identity can still be guaranteed, and the purpose of preservation and transportation can be achieved. The dry cornea has the necessary conditions for industrialization and marketization as a product, which is beneficial to the market promotion of artificial cornea. In addition, tests have shown that the dried cornea obtained by the drying method of the present invention has a mechanical processing property similar to that of a chemical contact lens when the water content is less than 10 to 15%. It is convenient to accurately process the shape of the cornea according to the requirements to achieve the special needs of corneal grafting. In particular, the processing of dry corneal diopter, the application of artificial cornea in refractive correction. The biomatrix cornea of the present invention has incomparable biocompatibility with respect to chemical contact lenses.
针对上述各实施方式的详细解释, 其目的仅在于对本发明进行解释, 以便于能够 更好地理解本发明, 但是, 这些描述不能以任何理由解释成是对本发明的限制, 特别是,在不同的实施方式中描述的各个特征也可以相互任意组合, 从而组成其 他实施方式, 除了有明确相反的描述,这些特征应被理解为能够应用于任何一个 实施方式中, 而并不仅局限于所描述的实施方式。 The detailed description of the various embodiments described above is intended to be illustrative of the present invention in order to provide a better understanding of the invention, but the description should not be construed as limiting the invention in any way, particularly The various features described in the embodiments can also be arbitrarily combined with each other to form other embodiments, and the features are to be understood as being applicable to any one embodiment, and not limited to the described embodiments. the way.

Claims

权 利 要 求 Rights request
1、 一种脱细胞角膜的干燥方法, 先将欲干燥角膜放置于承托装置上, 放入 真空度可调的密闭干燥室内;通过真空调节系统降低密闭干燥室内的压力低于大 气压力; 其特征在于, 调节密闭干燥室的压力在一时间段内逐渐减压至设定的最 大真空度时的压力,并在设定的最大真空度状态下持续至达到角膜干燥度的要求。 1. A method for drying a decellularized cornea, first placing the cornea to be dried on a support device, and placing it in a closed drying chamber with adjustable vacuum; and reducing the pressure in the closed drying chamber to below atmospheric pressure by a vacuum regulating system; The method is characterized in that the pressure of the closed drying chamber is gradually reduced to a pressure at a set maximum vacuum for a period of time, and continues to reach the requirement of corneal dryness under the set maximum vacuum state.
2、 如权利要求 1所述的脱细胞角膜的干燥方法, 其特征在于, 所述密闭干 燥室内的减压方式为至少两级自高向低梯度减压,在每一级的压力梯度上持续一 时间段; 最后一级梯度压力再减压至设定的最大真空度状态。  The method for drying acellular cornea according to claim 1, wherein the decompression mode in the closed drying chamber is at least two stages from high to low gradient decompression, and continues at a pressure gradient of each stage. A period of time; the final stage gradient pressure is then depressurized to a set maximum vacuum state.
3、 如权利要求 1所述的脱细胞角膜的干燥方法, 其特征在于, 所述控制密 闭干燥室内的减压方式为在一时间段内连续减压至设定的最大真空度状态。  The method for drying a decellularized cornea according to claim 1, wherein the method of controlling the decompression in the closed drying chamber is continuous depressurization to a set maximum vacuum state for a period of time.
4、 如权利要求 1所述的脱细胞角膜的干燥方法, 其特征在于, 所述密闭干 燥室内的温度控制在 0°C~30°C内。  The method for drying a decellularized cornea according to claim 1, wherein the temperature in the sealed dry chamber is controlled within a range of 0 ° C to 30 ° C.
5、 如权利要求 1所述的脱细胞角膜的干燥方法, 其特征在于, 所述真空调 节系统调节密闭干燥室的压力在 24小时之内,减压至设定的最大真空度时的压力。  The method for drying a decellularized cornea according to claim 1, wherein the true air-conditioning system adjusts the pressure at which the pressure in the closed drying chamber is reduced to a set maximum vacuum within 24 hours.
6、 如权利要求 5所述的脱细胞角膜的干燥方法, 其特征在于, 所述调节密 闭干燥室内减压至设定的最大真空度时的优选减压时间为 6-12小时。  The method for drying a decellularized cornea according to claim 5, wherein the preferred decompression time for adjusting the pressure in the closed drying chamber to a set maximum vacuum is 6 to 12 hours.
7、 如权利要求 1所述的脱细胞角膜的干燥方法, 其特征在于, 所述密闭干 燥室的压力调节范围为常压至设定的最大真空度。  The method for drying an acellular cornea according to claim 1, wherein the pressure-regulating range of the sealed drying chamber is from a normal pressure to a set maximum vacuum.
8、 如权利要求 1所述的脱细胞角膜的干燥方法, 其特征在于, 所述设定的 最大真空度时的压力为接近极限真空。  The method of drying a decellularized cornea according to claim 1, wherein the pressure at the set maximum degree of vacuum is close to an ultimate vacuum.
9、 如权利要求 2所述的脱细胞角膜的干燥方法, 其特征在于, 所述每级梯 度的减压范围为 10~100kpa。  The method for drying a decellularized cornea according to claim 2, wherein the decompression range of each step is 10 to 100 kPa.
10、 如权利要求 9所述的脱细胞角膜的干燥方法, 其特征在于, 所述每级梯 度的优选减压范围为 10~30kpa。  The method for drying a decellularized cornea according to claim 9, wherein the preferred decompression range of each step is 10 to 30 kPa.
11、 如权利要求 8所述的脱细胞角膜的干燥方法, 其特征在于, 每一级的压 力梯度上持续时间设定为随压力的变化而变化。 11. A method of drying a decellularized cornea according to claim 8, wherein the duration of the pressure gradient for each stage is set to vary with changes in pressure.
12、 如权利要求 2所述的脱细胞角膜的干燥方法, 其特征在于, 压力梯度变 化时所述真空调节系统调节前一级压力挡直接调节至后一级压力挡。 12. The method of drying a decellularized cornea according to claim 2, wherein the vacuum regulating system adjusts the first stage pressure block to directly adjust to the second stage pressure block when the pressure gradient changes.
13、 如权利要求 2所述的脱细胞角膜的干燥方法, 其特征在于, 压力梯度变 化时所述真空调节系统调节前一级压力挡逐渐降低到后一级压力挡。  The method for drying a decellularized cornea according to claim 2, wherein the vacuum regulating system adjusts the pressure of the first stage to gradually decrease to the pressure of the latter stage when the pressure gradient changes.
14、 如权利要求 2所述的脱细胞角膜的干燥方法, 其特征在于, 所述每级 减压梯度的持续时间段为 0.5~12小时。  The method for drying a decellularized cornea according to claim 2, wherein the duration of each of the decompression gradients is 0.5 to 12 hours.
15、 如权利要求 14所述的脱细胞角膜的干燥方法, 其特征在于, 所述每级 减压梯度的优选持续时间段为 0.5~4小时。  The method of drying a decellularized cornea according to claim 14, wherein the preferred duration of each of the reduced pressure gradients is 0.5 to 4 hours.
16、 如权利要求 1所述的脱细胞角膜的干燥方法, 其特征在于, 角膜干燥度 依据角膜含水率设定。  The method of drying a decellularized cornea according to claim 1, wherein the corneal dryness is set in accordance with a corneal moisture content.
17、 如权利要求 15所述的脱细胞角膜的干燥方法, 其特征在于, 角膜干燥 度设定为含水率不大于 20%。  The method for drying acellular cornea according to claim 15, wherein the corneal dryness is set to a moisture content of not more than 20%.
18、 一种脱细胞猪板层干燥角膜, 经过脱细胞处理的猪角膜前弹力层和基质 层构成其特征在于, 所述干燥角膜由上述权利要求 1~16任意一干燥方法获得。  18. A decellularized porcine lamellar dried cornea, the decellularized porcine corneal anterior elastic layer and a matrix layer, characterized in that the dried cornea is obtained by any of the drying methods according to any one of claims 1 to 16.
19、 如权利要求 18所述的一种脱细胞猪板层干燥角膜, 其特征在于, 干燥 角膜的含水率大于 0%且不大于 20%。  19. A decellularized pig lamellar dried cornea according to claim 18, wherein the dried cornea has a moisture content of greater than 0% and not greater than 20%.
20、 如权利要求 18所述的一种脱细胞猪板层干燥角膜, 其特征在于, 干燥 角膜的透光率不低于 70%。  20. A decellularized pig layer dried cornea according to claim 18, wherein the dried cornea has a light transmittance of not less than 70%.
21、 如权利要求 18所述的一种脱细胞猪板层干燥角膜, 其特征在于干燥角 膜表面平整, 无肉眼可见的嵴状突起或者细小褶皱。  21. A decellularized porcine lamellar dried cornea according to claim 18, wherein the surface of the dried keratome is flat without macroscopic ridges or fine pleats.
PCT/CN2016/110464 2016-12-16 2016-12-16 Method of drying decellularized cornea and dried decellularized pig lamellar cornea WO2018107486A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/CN2016/110464 WO2018107486A1 (en) 2016-12-16 2016-12-16 Method of drying decellularized cornea and dried decellularized pig lamellar cornea
CN201680077793.4A CN109069264B (en) 2016-12-16 2016-12-16 Drying method of acellular cornea and acellular pig lamina layer dried cornea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2016/110464 WO2018107486A1 (en) 2016-12-16 2016-12-16 Method of drying decellularized cornea and dried decellularized pig lamellar cornea

Publications (1)

Publication Number Publication Date
WO2018107486A1 true WO2018107486A1 (en) 2018-06-21

Family

ID=62557661

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/110464 WO2018107486A1 (en) 2016-12-16 2016-12-16 Method of drying decellularized cornea and dried decellularized pig lamellar cornea

Country Status (2)

Country Link
CN (1) CN109069264B (en)
WO (1) WO2018107486A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109579454A (en) * 2018-12-19 2019-04-05 山东省眼科医院 A method of it maintaining the drier of cornea sizing and maintains cornea sizing
WO2021094780A1 (en) * 2019-11-13 2021-05-20 The University Of Nottingham Corneal tissue

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101947144A (en) * 2010-09-29 2011-01-19 厦门大学 Ply tissue engineering corneal frame and manufacturing method and application thereof
CN101985051A (en) * 2010-10-21 2011-03-16 暨南大学 Acellular cornea or acellular corneal stroma, preparation method and application thereof
WO2011154687A1 (en) * 2010-06-11 2011-12-15 Ucl Business Plc Biomimetic corneal tissue
CN104001214A (en) * 2014-05-28 2014-08-27 青岛中皓生物工程有限公司 Lamellar corneal stroma bracket as well as preparation method and application thereof
CN104645415A (en) * 2014-11-28 2015-05-27 南昌大学第一附属医院 Method for preparing decellularized lamellar cornea matrix sheet
CN104665956A (en) * 2015-02-12 2015-06-03 厦门大开医疗器械有限公司 Preparation method for artificial corneas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110212524A1 (en) * 2006-12-04 2011-09-01 Body Organ Biomedical Corporation Biomaterial and preparation method thereof
CN102599991A (en) * 2012-03-20 2012-07-25 中山大学中山眼科中心 Application of beautifying cornea lens

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011154687A1 (en) * 2010-06-11 2011-12-15 Ucl Business Plc Biomimetic corneal tissue
CN101947144A (en) * 2010-09-29 2011-01-19 厦门大学 Ply tissue engineering corneal frame and manufacturing method and application thereof
CN101985051A (en) * 2010-10-21 2011-03-16 暨南大学 Acellular cornea or acellular corneal stroma, preparation method and application thereof
CN104001214A (en) * 2014-05-28 2014-08-27 青岛中皓生物工程有限公司 Lamellar corneal stroma bracket as well as preparation method and application thereof
CN104645415A (en) * 2014-11-28 2015-05-27 南昌大学第一附属医院 Method for preparing decellularized lamellar cornea matrix sheet
CN104665956A (en) * 2015-02-12 2015-06-03 厦门大开医疗器械有限公司 Preparation method for artificial corneas

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZHONG PINGHAI, ET AL.: "The Production Technology of Bio-chemicals", 31 May 2007, JIANGXI SCIENCE AND TECH PUBLISHING HOUSE, pages: 101 - 106 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109579454A (en) * 2018-12-19 2019-04-05 山东省眼科医院 A method of it maintaining the drier of cornea sizing and maintains cornea sizing
WO2021094780A1 (en) * 2019-11-13 2021-05-20 The University Of Nottingham Corneal tissue

Also Published As

Publication number Publication date
CN109069264A (en) 2018-12-21
CN109069264B (en) 2020-06-30

Similar Documents

Publication Publication Date Title
EP1932549B1 (en) Dried amnion and method for drying treatment of amnion
Liang et al. Fabrication and characters of a corneal endothelial cells scaffold based on chitosan
RU2478403C2 (en) Sterile autologous, allogenic or xenogenic implants and method for making it
JPH05117162A (en) Nonporous collagen sheet for treatment and process and apparatus for preparing same
US10098986B1 (en) Ready to use biodegradable and biocompatible artificial skin substitute and a method of preparation thereof
CN100368534C (en) Bioderived amnion, composite bioderived amnion and its preparation method
WO2018107486A1 (en) Method of drying decellularized cornea and dried decellularized pig lamellar cornea
CN101437939B (en) The amplification method of human corneal endothelial cells
WO2018107484A1 (en) Decellurization method for swine cornea, decellularized cornea thereof, and use method for dried lamellar cornea
CN109475663B (en) Preparation method of acellular porcine cornea, acellular lamellar cornea and use method of acellular lamellar cornea
CN115554467B (en) Skull repairing material and preparation method thereof
JP2003126236A (en) Porous support body prepared from biodegradable polymer for regeneration of damaged ocular tissue
US20120226363A1 (en) Method for manufacturing a device for regenerating biological tissues
CN110975012B (en) Method for preparing de-epithelialized amniotic membrane
CN102671243A (en) Quaternized chitosan/siRNA composite particle-loaded skin regeneration material and preparation method thereof
WO2018107485A1 (en) Decellularized dried swine lamellar cornea, used method for same, and uses thereof
CN105854087B (en) A kind of cornea repair material and preparation method thereof with matrix repair ability
CN111686297A (en) Antibacterial active dressing and preparation method thereof
CN111214710A (en) Composite scaffold for promoting skin regeneration and preparation method thereof
CN109363801A (en) A kind of method that femtosecond laser technology auxiliary prepares porcine cornea endothelium plant piece
TWI842984B (en) A freeze-dried powder of mesenchymal stem cell and the fabrication method thereof
Maguen et al. A new technique for lathing lyophilized cornea for refractive keratoplasty
JP2008199972A (en) Method for producing cultured multilayer epithelium sheet
WO2023100067A1 (en) Production process of a pulverized scaffold
Sharma et al. Limbal stem cell transplants and amniotic membrane grafts in ocular surface disease: current perspectives.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16923722

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16923722

Country of ref document: EP

Kind code of ref document: A1